103 results on '"LAURIA C"'
Search Results
2. On the optimality of score-driven models.
- Author
-
Gorgi, P, Lauria, C S A, and Luati, A
- Subjects
- *
BIOMETRY , *DENSITY , *GENERALIZATION , *DEFINITIONS - Abstract
Score-driven models have recently been introduced as a general framework to specify time-varying parameters of conditional densities. The score enjoys stochastic properties that make these models easy to implement and convenient to apply in several contexts, ranging from biostatistics to finance. Score-driven parameter updates have been shown to be optimal in terms of locally reducing a local version of the Kullback–Leibler divergence between the true conditional density and the postulated density of the model. A key limitation of such an optimality property is that it holds only locally both in the parameter space and sample space, yielding to a definition of local Kullback–Leibler divergence that is in fact not a divergence measure. The current paper shows that score-driven updates satisfy stronger optimality properties that are based on a global definition of Kullback–Leibler divergence. In particular, it is shown that score-driven updates reduce the distance between the expected updated parameter and the pseudo-true parameter. Furthermore, depending on the conditional density and the scaling of the score, the optimality result can hold globally over the parameter space, which can be viewed as a generalization of the monotonicity property of the stochastic gradient descent scheme. Several examples illustrate how the results derived in the paper apply to specific models under different easy-to-check assumptions, and provide a formal method to select the link function and the scaling of the score. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. On the optimality of score-driven models
- Author
-
Gorgi, P, primary, Lauria, C S A, additional, and Luati, A, additional
- Published
- 2023
- Full Text
- View/download PDF
4. Echocardiographic markers of early alcoholic cardiomyopathy: Six-month longitudinal study in heavy drinking patients
- Author
-
Mirijello, Antonio, Sestito, Luisa, Lauria, C, Tarli, Claudia, Vassallo, Ga, D'Angelo, C, Ferrulli, A, Crea, Filippo, Cossari, A, Leggio, L, De Cosmo, S, Gasbarrini, Antonio, Addolorato, Giovanni, Antonelli, M, Mirijello A, Sestito L, Tarli C, Crea F (ORCID:0000-0001-9404-8846), Gasbarrini A (ORCID:0000-0002-7278-4823), Addolorato G. (ORCID:0000-0002-1522-9946), Mirijello, Antonio, Sestito, Luisa, Lauria, C, Tarli, Claudia, Vassallo, Ga, D'Angelo, C, Ferrulli, A, Crea, Filippo, Cossari, A, Leggio, L, De Cosmo, S, Gasbarrini, Antonio, Addolorato, Giovanni, Antonelli, M, Mirijello A, Sestito L, Tarli C, Crea F (ORCID:0000-0001-9404-8846), Gasbarrini A (ORCID:0000-0002-7278-4823), and Addolorato G. (ORCID:0000-0002-1522-9946)
- Abstract
Background: The development of alcoholic cardiomyopathy (ACM) is related to chronic excessive alcohol use. However, features of early-stage ACM are still unclear. We assessed echocardiographic characteristics of patients with alcohol dependence (DSM-IV criteria) during a six-month treatment period. Methods: Active drinking patients, heavy alcohol users, without heart disease, referred to our Alcohol Addiction Unit were enrolled in the study. After signing informed consent, patients started outpatient treatment program. Echocardiography was performed at enrollment, then three and six months afterwards, by cardiologists blinded to drinking status. Results: Forty-three patients (36 males, 7 females) were enrolled. At six months, 20 patients (46.5%) reduced alcohol consumption below heavy drinking levels. Although within normal range, baseline mean IVS thickness and mean LVDD were significantly higher (p < 0.001) and mean EF significantly reduced (p = 0.009), as compared to age-matched mean references. Mean E/A ratio, DcT and LA diameter were significantly different (p < 0.001) from mean references, but within normal range. Baseline mean E/e' ratio was significantly higher than the mean reference (p < 0.001) and out of the normal range. A significant correlation between the number of drinks per drinking days in the 7 days before baseline assessment and E/e' ratio was observed (p = 0.028). After six months, a trend-level reduction of mean E/e' ratio (p = 0.051) was found in the whole sample; this reduction was statistically significant (p = 0.041) among patients reducing drinking, compared to baseline. Conclusions: Altered E/e' ratio may characterize early-ACM before the occurrence of relevant echocardiographic alterations. The reduction of alcohol consumption could restore this alteration after six months.
- Published
- 2022
5. Energy intake and sources of energy intake in the European Prospective Investigation into Cancer and Nutrition
- Author
-
Ocke, M.C., Larranaga, N., Grioni, S., van den Berg, S.W., Ferrari, P., Salvini, S., Benetou, V., Linseisen, J., Wirfalt, E., Rinaldi, S., Jenab, M., Halkjaer, J., Jakobsen, M.U., Niravong, M., Clavel-Chapelon, F., Kaaks, R., Bergmann, M., Moutsiou, E., Trichopoulou, A., Lauria, C., Sacerdote, C., Bueno-de-Mesquita, H.B., Peeters, P.H.M., Hjartaker, A., Parr, C.L., Tormo, M.J., Sanchez, M.J., Manjer, J., Hellstrom, V., Mulligan, A., Spencer, E.A., Riboli, E., Bingham, S., and Slimani, N.
- Subjects
Research ,Demographic aspects ,Methods ,Health aspects ,Human nutrition -- Research -- Methods -- Health aspects ,Cancer research -- Methods -- Health aspects ,Diet -- Health aspects -- Demographic aspects -- Research -- Methods ,Oncology, Experimental -- Methods -- Health aspects ,Cancer -- Research - Abstract
Introduction Nowadays, in Europe, an enormously rich variety of foods is available on the market, and this very abundance, especially of energy-dense foods and drinks, is considered to be one [...], Objectives: To describe energy intake and its macronutrient and food sources among 27 regions in 10 countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Methods: Between 1995 and 2000, 36034 subjects aged 35-74 years were administered a standardized 24-h dietary recall. Intakes of macronutrients (g/day) and energy (kcal/day) were estimated using standardized national nutrient databases. Mean intakes were weighted by season and day of the week and were adjusted for age, height and weight, after stratification by gender. Extreme low- and high-energy reporters were identified using Goldberg's cutoff points (ratio of energy intake and estimated basal metabolic rate 2.72), and their effects on macronutrient and energy intakes were studied. Results: Low-energy reporting was more prevalent in women than in men. The exclusion of extreme-energy reporters substantially lowered the EPIC-wide range in mean energy intake from 2196-2877 to 2309-2866 kcal among men. For women, these ranges were 1659-2070 and 1873-2108 kcal. There was no north-south gradient in energy intake or in the prevalence of low-energy reporting. In most centres, cereals and cereal products were the largest contributors to energy intake. The food groups meat, dairy products and fats and oils were also important energy sources. In many centres, the highest mean energy intakes were observed on Saturdays. Conclusions: These data highlight and quantify the variations and similarities in energy intake and sources of energy intake among 10 European countries. The prevalence of low-energy reporting indicates that the study of energy intake is hampered by the problem of underreporting. Keywords: energy intake; underreporting; dietary fat; 24-h dietary recall; Europe; EPIC-soft doi: 10.1038/ejcn.2009.72
- Published
- 2009
- Full Text
- View/download PDF
6. Poster Session: Right ventricular systolic function
- Author
-
Sestito, A, Lamendola, P, Di Franco, A, Lauria, C, and Lanza, GA
- Published
- 2012
7. Contribution of highly industrially processed foods to the nutrient intakes and patterns of middle-aged populations in the European Prospective Investigation into Cancer and Nutrition study
- Author
-
Slimani, N, Deharveng, G, Southgate, DAT, Biessy, C, Chajès, V, van Bakel, MME, Boutron-Ruault, M C, McTaggart, A, Grioni, S, Verkaik-Kloosterman, J, Huybrechts, I, Amiano, P, Jenab, M, Vignat, J, Bouckaert, K, Casagrande, C, Ferrari, P, Zourna, P, Trichopoulou, A, Wirfält, E, Johansson, G, Rohrmann, S, Illner, A-K, Barricarte, A, Rodríguez, L, Touvier, M, Niravong, M, Mulligan, A, Crowe, F, Ocké, M C, van der Schouw, Y T, Bendinelli, B, Lauria, C, Brustad, M, Hjartåker, A, Tjønneland, A, Jensen, A M, Riboli, E, and Bingham, S
- Published
- 2009
8. Treatment of classic Kaposi sarcoma with a nicotine dermal patch: a phase II clinical trial
- Author
-
Goedert, J J, Scoppio, B M, Pfeiffer, R, Neve, L, Federici, A B, Long, L R, Dolan, B M, Brambati, M, Bellinvia, M, Lauria, C, Preiss, L, Boneschi, V, Whitby, D, and Brambilla, L
- Published
- 2008
9. Indicazioni per uno Studio su Familiarità e fattori di rischio del Sarcoma di Kaposi classico
- Author
-
Lauria, C., Nasca, M., Goedert, J., Vitale, F., Gafà, R., Magro, G., Vasquez, E., Latteri, F., Risitano, G., Lunghi, G., Di Stefano, R., Matranga, D., Muriana, S., Micali, G., Lentini, M., Brambilla, L., Lauria, C, Nasca, MR, Goedert, JJ, Vitale, F, Gafà, R, Magro, G, Vasquez, E, Latteri, F, Risitano, G, Lunghi,G, Di Stefano, R, Matranga, D, Muriana, S, Micali, G, Lentini M, and Brambilla, L
- Subjects
Settore MED/42 - Igiene Generale E Applicata ,kaposi ,Settore MED/01 - Statistica Medica - Abstract
Obiettivi: Dalle analisi dei dati degli studi precedenti effettuati in Sicilia sono emerse diverse indicazioni, per cui è stata avviata un’indagine in Sicilia nel 2013 , grazie ad un finanziamento della LILT nazionale, intesa a: valutare la situazione immunologica ed ematochimica e la sieroprevalenza in persone a stretto contatto con i malati (parente di 1 grado o marito/moglie) o parenti affetti dalla stessa patologia; indagare alcuni fattori di rischio con un questionario;effettuare il follow-up dei malati ogni 6-12-18-24 mesi ; individuare un Centro di Riferimento in Sicilia per la diagnosi e cura di questo tumore raro. Materiali e Metodi: Sono stati arruolati 24 Casi (21M/3F) e 27 Controlli familiari (9M/18F), residenti in Sicilia e solo un caso di sesso maschile residente in Calabria. La casistica non include 3 casi maschi perché arruolati per la seconda volta al follow-up ; inoltre 1 caso M e relativo controllo (moglie) è stato escluso in quanto affetto da altro tipo di Sarcoma. I controlli sono stati familiari consanguinei e/o non consanguinei ( moglie, marito, genero ecc..) di casi in cura presso le Università di Catania e Messina oppure già arruolati negli studi precedenti dalla LILT di Ragusa, alcuni dei quali deceduti. Risultati: Dal confronto tra Controlli HHV8 positivi (n°11) vs. Controlli HHV8 negativi (n°16) non sono state individuate differenze significative a eta’, sesso, livello d’istruzione, occupazione e varie esposizione ambientali (età : >64 vs
- Published
- 2016
10. Osteogenic transdifferentiation of primary human fibroblasts to osteoblast-like cells with human platelet lysate
- Author
-
Ferdy K. Cayami, Lauria Claeys, Ruben de Ruiter, Bernard J. Smilde, Lisanne Wisse, Natalija Bogunovic, Elise Riesebos, Lyra Eken, Irsan Kooi, Erik A. Sistermans, Nathalie Bravenboer, Gerard Pals, Sultana M. H. Faradz, Daoud Sie, E. Marelise W. Eekhoff, and Dimitra Micha
- Subjects
Medicine ,Science - Abstract
Abstract Inherited bone disorders account for about 10% of documented Mendelian disorders and are associated with high financial burden. Their study requires osteoblasts which play a critical role in regulating the development and maintenance of bone tissue. However, bone tissue is not always available from patients. We developed a highly efficient platelet lysate-based approach to directly transdifferentiate skin-derived human fibroblasts to osteoblast-like cells. We extensively characterized our in vitro model by examining the expression of osteoblast-specific markers during the transdifferentiation process both at the mRNA and protein level. The transdifferentiated osteoblast-like cells showed significantly increased expression of a panel of osteogenic markers. Mineral deposition and ALP activity were also shown, confirming their osteogenic properties. RNA-seq analysis allowed the global study of changes in the transcriptome of the transdifferentiated cells. The transdifferentiated cells clustered separately from the primary fibroblasts with regard to the significantly upregulated genes indicating a distinct transcriptome profile; transdifferentiated osteoblasts also showed significant enrichment in gene expression related to skeletal development and bone mineralization. Our presented in vitro model may potentially contribute to the prospect of studying osteoblast-dependent disorders in patient-derived cells.
- Published
- 2022
- Full Text
- View/download PDF
11. Studio sull’incapsulamento di microtalee vitro-derivate di gelso
- Author
-
Casales, FG, Chiancone, B, Lauria, C, GERMANA', Maria, Casales, FG, Chiancone, B, Lauria, C, and Germanà, M
- Subjects
Settore AGR/03 - Arboricoltura Generale E Coltivazioni Arboree ,Gelso, seme sintetico, coltura in vitro - Published
- 2012
12. Exploration of the skeletal phenotype of the Col1a1+/Mov13 mouse model for haploinsufficient osteogenesis imperfecta type 1
- Author
-
Lauria Claeys, Lidiia Zhytnik, Lisanne E. Wisse, Huib W. van Essen, E. Marelise W. Eekhoff, Gerard Pals, Nathalie Bravenboer, and Dimitra Micha
- Subjects
Mov13 ,osteogenesis imperfecta ,Col1a1 ,haploinsufficient ,bone ,collagen ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
IntroductionOsteogenesis Imperfecta is a rare genetic connective tissue disorder, characterized by skeletal dysplasia and fragile bones. Currently only two mouse models have been reported for haploinsufficient (HI) mild Osteogenesis Imperfecta (OI); the Col1a1+/Mov13 (Mov13) and the Col1a1+/-365 mouse model. The Mov13 mice were created by random insertion of the Mouse Moloney leukemia virus in the first intron of the Col1a1 gene, preventing the initiation of transcription. Since the development of the Mov13 mice almost four decades ago and its basic phenotypic characterization in the 90s, there have not been many further studies. We aimed to extensively characterize the Mov13 mouse model in order to critically evaluate its possible use for preclinical studies of HI OI.MethodsBone tissue from ten heterozygous Mov13 and ten wild-type littermates (WT) C57BL/6J mice (50% males per group) was analyzed at eight weeks of age with bone histomorphometry, micro computed tomography (microCT), 3-point bending, gene expression of different collagens, as well as serum markers of bone turnoverResultsThe Mov13 mouse presented a lower bone strength and impaired material properties based on our results of 3-point bending and microCT analysis respectively. In contrast, no significant differences were found for all histomorphometric parameters. In addition, no significant differences in Col1a1 bone expression were present, but there was a significant lower P1NP concentration, a bone formation marker, measured in serum. Furthermore, bone tissue of Mov13 mice presented significantly higher expression of collagens (Col1a2, Col5a1 and Col5a2), and bone metabolism markers (Bglap, Fgf23, Smad7, Edn1 and Eln) compared to WT. Finally, we measured a significantly lower Col1a1 expression in heart and skin tissue and also determined a higher expression of other collagens in the heart tissue.ConclusionAlthough we did not detect a significant reduction in Col1a1 expression in the bone tissue, a change in bone structure and reduction in bone strength was noted. Regrettably, the variability of the bone phenotype and the appearance of severe lymphoma in adult Mov13 mice, does not favor their use for the testing of new long-term drug studies. As such, a new HI OI type 1 mouse model is urgently needed.
- Published
- 2023
- Full Text
- View/download PDF
13. Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity
- Author
-
Brown, E. E., Fallin, D., Ruczinski, I., Hutchinson, A., Staats, B., Vitale, F., Lauria, C., Serraino, D., Rezza, G., Mbisa, G., Whitby, D., Messina, A., Goedert, J. J., Chanock, S. J., Romano, N., Ajello, F., Bonura, F., Perna, A. M., Viviano, E., Tramuto, F., Villafrate, M. R., Di Benedetto, M. A., Tamburini, M., Montella, M., Crispo, A., de Sicato, S., de Marco, M. R., Ascierto, P., Piselli, P., Valdarchi, C., Farchi, F., Corona, R. M., Di Carlo, A., Castilletti, C., Gafa, L., Stella, S., Massimino, M., Kroner, B., Chatterjee, N., Chen, J., Kiley, M., Chen, R., BROWN EE, FALLIN D, RUCZINSKI I, HUTCHINSON A, STAATS B, VITALE F, LAURIA C, SERRAINO D, REZZA G, MBISA G, WHITBY D, MESSINA A, GOEDERT JJ, CHANOCK SJ, KAPOSI SARCOMA WORKING GROUP, and Tramuto, F.
- Subjects
Adult ,Male ,Genotype ,Epidemiology ,Population ,Single-nucleotide polymorphism ,Biology ,Settore MED/42 - Igiene Generale E Applicata ,IL12A ,medicine ,Humans ,Genetic Predisposition to Disease ,Risk factor ,education ,Sarcoma, Kaposi ,Aged ,Aged, 80 and over ,education.field_of_study ,Classic Kaposi Sarcoma ,Polymorphism, Genetic ,Case-control study ,Cancer ,Herpesvirus Infection ,Odds ratio ,Middle Aged ,medicine.disease ,Oncology ,Haplotypes ,Italy ,Genetic Variant ,Case-Control Studies ,Immunology ,Herpesvirus 8, Human ,Cytokines ,Female - Abstract
Classic Kaposi sarcoma (CKS) is an inflammatory-mediated neoplasm primarily caused by Kaposi sarcoma–associated herpesvirus (KSHV). Kaposi sarcoma lesions are characterized, in part, by the presence of proinflammatory cytokines and growth factors thought to regulate KSHV replication and CKS pathogenesis. Using genomic DNA extracted from 133 CKS cases and 172 KSHV-latent nuclear antigen-positive, population-based controls in Italy without HIV infection, we examined the risk of CKS associated with 28 common genetic variants in 14 immune-modulating genes. Haplotypes were estimated for IL1A, IL1B, IL4, IL8, IL8RB, IL10, IL12A, IL13, and TNF. Compared with controls, CKS risk was decreased with 1235T/−1010G–containing diplotypes of IL8RB (odds ratio, 0.49; 95% confidence interval, 0.30-0.78; P = 0.003), whereas risk was increased with diplotypes of IL13 containing the promoter region variant 98A (rs20541, alias +130; odds ratio, 1.88; 95% confidence interval, 1.15-3.08; P = 0.01) when considered in multivariate analysis. Risk estimates did not substantially vary by age, sex, incident disease, or disease burden. Our data provide preliminary evidence for variants in immune-modulating genes that could influence the risk of CKS. Among KSHV-seropositive Italians, CKS risk was associated with diplotypes of IL8RB and IL13, supporting laboratory evidence of immune-mediated pathogenesis. (Cancer Epidemiol Biomarkers Prev 2006;15(5):926–34)
- Published
- 2006
14. A common genetic variant in FCGR3A-V158F and risk of Kaposi Sarcoma Herpesvirus infection and classic Kaposi Sarcoma
- Author
-
BROWN EE, FALLIN MD, GOEDERT JJ, CHEN R, WHITBY D, FOSTER CB, LAURIA C, ALBERG AJ, MESSINA A, MONTELLA M, REZZA G, CHANOCK SJ, VITALE, Francesco, BROWN EE, FALLIN MD, GOEDERT JJ, CHEN R, WHITBY D, FOSTER CB, LAURIA C, ALBERG AJ, MESSINA A, MONTELLA M, REZZA G, VITALE F, and CHANOCK SJ
- Published
- 2005
15. Poor tolerance and limited effects of isosorbide-5-mononitrate in microvascular angina
- Author
-
Wu, M, Villano, Angelo, Russo, Giulio, Di Franco, Antonino, Stazi, Alessandra, Lauria, C, Sestito, Alfonso, Lanza, Gaetano Antonio, Crea, Filippo, Sestito, Alfonso (ORCID:0000-0001-9965-2997), Lanza, Gaetano Antonio (ORCID:0000-0003-2187-6653), Crea, Filippo (ORCID:0000-0001-9404-8846), Wu, M, Villano, Angelo, Russo, Giulio, Di Franco, Antonino, Stazi, Alessandra, Lauria, C, Sestito, Alfonso, Lanza, Gaetano Antonio, Crea, Filippo, Sestito, Alfonso (ORCID:0000-0001-9965-2997), Lanza, Gaetano Antonio (ORCID:0000-0003-2187-6653), and Crea, Filippo (ORCID:0000-0001-9404-8846)
- Published
- 2015
16. Contribution of highly industrially processed foods to the nutrient intakes and patterns of middle-aged populations in the European Prospective Investigation into Cancer and Nutrition study
- Author
-
Slimani, N. Deharveng, G. Southgate, D. A. T. Biessy, C. and Chajes, V. van Bakel, M. M. E. Boutron-Ruault, M. C. and McTaggart, A. Grioni, S. Verkaik-Kloosterman, J. Huybrechts, I. Amiano, P. Jenab, M. Vignat, J. Bouckaert, K. and Casagrande, C. Ferrari, P. Zourna, P. Trichopoulou, A. and Wirfalt, E. Johansson, G. Rohrmann, S. Illner, A-K and Barricarte, A. Rodriguez, L. Touvier, M. Niravong, M. and Mulligan, A. Crowe, F. Ocke, M. C. van der Schouw, Y. T. and Bendinelli, B. Lauria, C. Brustad, M. Hjartaker, A. and Tjonneland, A. Jensen, A. M. Riboli, E. Bingham, S.
- Subjects
digestive, oral, and skin physiology - Abstract
Objectives: To describe the contribution of highly processed foods to total diet, nutrient intakes and patterns among 27 redefined centres in the 10 countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC). Methods: Single 24-hour dietary recalls were collected from 36 034 individuals (aged 35-74 years) using a standardized computerized interview programme (EPIC-SOFT). Centre-specific mean food intakes (g/day) were computed according to their degree of food processing (that is, highly, moderately and non-processed foods) using a specifically designed classification system. The contribution (%) of highly processed foods to the centre mean intakes of diet and 26 nutrients (including energy) was estimated using a standardized nutrient database (ENDB). The effect of different possible confounders was also investigated. Results: Highly processed foods were an important source of the nutrients considered, contributing between 61% (Spain) and 78-79% (the Netherlands and Germany) of mean energy intakes. Only two nutrients, beta-carotene (34-46%) and vitamin C (28-36%), had a contribution from highly processed foods below 50% in Nordic countries, in Germany, the Netherlands and the United Kingdom, whereas for the other nutrients, the contribution varied from 50 to 91% (excluding alcohol). In southern countries (Greece, Spain, Italy and France), the overall contribution of highly processed foods to nutrient intakes was lower and consisted largely of staple or basic foods (for example, bread, pasta/rice, milk, vegetable oils), whereas highly processed foods such as crisp bread, breakfast cereals, margarine and other commercial foods contributed more in Nordic and central European centres. Conclusions: Highly industrially processed foods dominate diets and nutrient patterns in Nordic and central European countries. The greater variations observed within southern countries may reflect both a larger contribution of non/moderately processed staple foods along with a move from traditional to more industrialized dietary patterns. European Journal of Clinical Nutrition (2009) 63, S206-S225; doi: 10.1038/ejcn.2009.82
- Published
- 2009
17. Energy intake and sources of energy intake in the European Prospective Investigation into Cancer and Nutrition
- Author
-
Ocke, M. C. Larranaga, N. Grioni, S. van den Berg, S. W. and Ferrari, P. Salvini, S. Benetou, V. Linseisen, J. and Wirfalt, E. Rinaldi, S. Jenab, M. Halkjaer, J. Jakobsen, M. U. Niravong, M. Clavel-Chapelon, F. Kaaks, R. and Bergmann, M. Moutsiou, E. Trichopoulou, A. Lauria, C. and Sacerdote, C. Bueno-de-Mesquita, H. B. Peeters, P. H. M. and Hjartaker, A. Parr, C. L. Tormo, M. J. Sanchez, M. J. and Manjer, J. Hellstrom, V. Mulligan, A. Spencer, E. A. and Riboli, E. Bingham, S. Slimani, N.
- Abstract
Objectives: To describe energy intake and its macronutrient and food sources among 27 regions in 10 countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Methods: Between 1995 and 2000, 36 034 subjects aged 35-74 years were administered a standardized 24-h dietary recall. Intakes of macronutrients (g/day) and energy (kcal/day) were estimated using standardized national nutrient databases. Mean intakes were weighted by season and day of the week and were adjusted for age, height and weight, after stratification by gender. Extreme low- and high-energy reporters were identified using Goldberg’s cutoff points (ratio of energy intake and estimated basal metabolic rate 2.72), and their effects on macronutrient and energy intakes were studied. Results: Low-energy reporting was more prevalent in women than in men. The exclusion of extreme-energy reporters substantially lowered the EPIC-wide range in mean energy intake from 2196-2877 to 2309-2866 kcal among men. For women, these ranges were 1659-2070 and 1873-2108 kcal. There was no north-south gradient in energy intake or in the prevalence of low-energy reporting. In most centres, cereals and cereal products were the largest contributors to energy intake. The food groups meat, dairy products and fats and oils were also important energy sources. In many centres, the highest mean energy intakes were observed on Saturdays. Conclusions: These data highlight and quantify the variations and similarities in energy intake and sources of energy intake among 10 European countries. The prevalence of low-energy reporting indicates that the study of energy intake is hampered by the problem of underreporting. European Journal of Clinical Nutrition (2009) 63, S3-S15; doi: 10.1038/ejcn.2009.72
- Published
- 2009
18. Correlates of Human Herpesvirus-8 DNA detection among adults in Italy without Kaposi sarcoma
- Author
-
Brown, E. E., Whitby, D., Vitale, F., Fei, P. C., Del Carpio, C., Marshall, V., Alberg, A. J., Serraino, D., Messina, A., Gafa, L., Goedert, J. J., Romano, N., Ajello, F., Bonura, F., Perna, A. M., Viviano, E., Tramuto, F., Villafrate, M. R., Di Benedetto, M. A., Tamburini, M., Montella, M., Crispo, A., De Sicato, S., De Marco, M. R., Ascierto, P., Piselli, P., Rezza, G., Valdarchi, C., Corona, R. M., Giuliani, M., Castilletti, C., Lauria, C., Laura, C., Stella, S., Massimino, M., Kroner, B., Biggar, R. J., Rabkin, C. S., BROWN EE, WHITBY D, VITALE F, CORDIALI FEI P, DEL CARPIO C, MARSHALL V, ALBERG AJ, SERRAINO D, MESSINA A, GAFA L, GOEDERT JJ, THE CLASSICAL KAPOSI SARCOMA WORKING GROUP, and Tramuto, F.
- Subjects
Male ,Epidemiology ,medicine.medical_treatment ,Comorbidity ,Settore MED/42 - Igiene Generale E Applicata ,medicine.disease_cause ,Kaposi sarcoma herpesvirus ,80 and over ,Leukocytes ,Gammaherpesvirinae ,Medicine ,HHV8 ,Viral ,Aged, 80 and over ,education.field_of_study ,biology ,virus diseases ,Immunosuppression ,General Medicine ,Herpesviridae Infections ,Middle Aged ,Viral Load ,Italy ,Herpesvirus 8, Human ,Female ,Antibody ,Kaposi sarcoma herpesviru ,Viral load ,Human ,Adult ,Viral DNA ,Population ,Mononuclear ,KSHV ,Peripheral blood mononuclear cell ,Herpesviridae ,Age Distribution ,Antigen ,Humans ,Herpesvirus 8 ,Sex Distribution ,education ,Aged ,business.industry ,Hemodynamics ,DNA ,biology.organism_classification ,Blood Cell Count ,Socioeconomic Factors ,Immunology ,DNA, Viral ,biology.protein ,Leukocytes, Mononuclear ,business - Abstract
Background: The presence of Human Herpesvirus-8 (HHV8) DNA is predictive of Kaposi sarcoma (KS) among patients with HIV-associated or iatrogenic immunosuppression. However, correlates of HHV8-DNA detection in the general population remain undefined. Methods: We assessed correlates of HHV8-DNA detection among Italian adults without KS who had antibodies against HHV8-latent nuclear antigen by immunofluorescence assay. HHV8-K6 DNA sequences were detected in peripheral blood mononuclear cells using TaqMan CR. Results: Of the 158 subjects 26 (16.5%) had detectable HHV8-DNA [median copies/million cells, 53; (13-2128)]. Adjusted for age, sex, and laboratory, HHV8-DNA was detected more frequently in participants with >7 total residents in the childhood home [OR = 3.7 (1.5-9.1)], >2 younger siblings [OR = 2.6 (1.1-6.5)], and current cardiovascular [OR = 3.6 (1.3-9.7)] or renal [OR = 3.1 (1.2-8.0)] disease. Excluding the participants using immune modulating drugs, HHV8-DNA was more frequent among those with low red blood cells (RBC) [92 μm3/red cell; OR = 2.8 (1.0-7.8)], and mild thrombocytopenia [
- Published
- 2005
19. Evaluation of under- and overreporting of energy intake in the 24-hour diet recalls in the European Prospective Investigation into Cancer and Nutrition (EPIC)
- Author
-
Ferrari, P. Slimani, N. Ciampi, A. Trichopoulou, A. Naska, A. Lauria, C. Veglia, F. Bueno-de-Mesquita, H.B. Ocké, M.C. Brustad, M. Braaten, T. Tormo, M.J. Amiano, P. Mattisson, I. Johansson, G. Welch, A. Davey, G. Overvad, K. Tjønneland, A. Clavel-Chapelon, F. Thiebaut, A. Linseisen, J. Boeing, H. Hemon, B. Riboli, E.
- Abstract
Objective: To evaluate under- and overreporting and their determinants in the EPIC 24-hour diet recall (24-HDR) measurements collected in the European Prospective Investigation into Cancer and Nutrition (EPIC). Design: Cross-sectional analysis. 24-HDR measurements were obtained by means of a standardised computerised interview program (EPIC-SOFT). The ratio of reported energy intake (EI) to estimated basal metabolic rate (BMR) was used to ascertain the magnitude, impact and determinants of misreporting. Goldberg's cut-off points were used to identify participants with physiologically extreme low or high energy intake. At the aggregate level the value of 1.55 for physical activity level (PAL) was chosen as reference. At the individual level we used multivariate statistical techniques to identify factors that could explain EI/BMR variability. Analyses were performed by adjusting for weight, height, age at recall, special diet, smoking status, day of recall (weekday vs. weekend day) and physical activity. Setting: Twenty-seven redefined centres in the 10 countries participating in the EPIC project. Subjects: In total, 35955 men and women, aged 35-74 years, participating in the nested EPIC calibration sub-studies. Results: While overreporting has only a minor impact, the percentage of subjects identified as extreme underreporters was 13.8% and 10.3% in women and men, respectively. Mean EI/BMR values in men and women were 1.44 and 1.36 including all subjects, and 1.50 and 1.44 after exclusion of misreporters. After exclusion of misreporters, adjusted EI/BMR means were consistently less than 10% different from the expected value of 1.55 for PAL (except for women in Greece and in the UK), with overall differences equal to 4.0% and 7.4% for men and women, respectively. We modelled the probability of being an underreporter in association with several individual characteristics. After adjustment for age, height, special diet, smoking status, day of recall and physical activity at work, logistic regression analyses resulted in an odds ratio (OR) of being an underreporter for the highest vs. the lowest quartile of body mass index (BMI) of 3.52 (95% confidence interval (CI) 2.91-4.26) in men and 4.80 (95% CI 4.11-5.61) in women, indicating that overweight subjects are significantly more likely to underestimate energy intake than subjects in the bottom BMI category. Older peoplewere less likely to underestimate energy intake: ORs were 0.58 (95% CI 0.45-0.77) and 0.74 (95% CI 0.63-0.88) for age (≥ 65 years vs. < 50 years). Special diet and day of the week showed strong effects. Conclusion: EI tends to be underestimated in the vast majority of the EPIC centres, although to varying degrees; at the aggregate level most centres were below the expected reference value of 1.55. Underreporting seems to be more prevalent among women than men in the EPIC calibration sample. The hypothesis that BMI (or weight) and age are causally related to underreporting seems to be confirmed in the present work. This introduces further complexity in the within-group (centre or country) and between-group calibration of dietary questionnaire measurements to deattenuate the diet-disease relationship.
- Published
- 2002
20. European Prospective Investigation into Cancer and Nutrition (APIC) calibration study:rationale, design and population characteristics
- Author
-
Slimani, N., Kaaks, R., Ferrari, P., Casagrande, C., Clavel-Chapelon, F., Lotze, G., Kroke, A., Trichopoulos, D., Trichopoulou, A., Lauria, C., Bellegotti, M., Ocke, M.C., Peeters, P.H.M., Engeset, D., Lund, E., Agudo, A, Larranaga, N., Mattisson, I., Andren, C, Johansson, I., Davey, G., Welch, A.A., Overvad, K., Tjonneland, A., van Staveren, W.A., Saracci, R., and Riboli, E.
- Published
- 2002
21. Evaluation of under- and overreporting of energy intake in the 24-hour diet recalls in the European Prospective Investigation into Cancer and Nutrition (EPIC)
- Author
-
Ferrari, P., Slimani, N., Ciampi, A., Trichopoulos, D., Naska, A., Lauria, C., Veglia, H.B., Bueno-de-Mesquita, M.C., Ocké, M., Brustad, M., Braaten, T., José, M., Tormo, P., Aamiano, P., Mattisson, I., Johansson, G., Welch, A., Davey, G., Overvad, K., Tjønneland, A., Clavel-Chapelon, F., Thiebaut, A., Linseisen, J., Boeing, H., Hemon, B., and Riboli, E.
- Published
- 2002
22. Energy intake and sources of energy intake in the European prospective investigation into cancer and nutrition
- Author
-
Ocké, M C, Larrañaga, N, Grioni, S, van den Berg, S W, Ferrari, P, Salvini, S, Benetou, V, Linseisen, J, Wirfält, E, Rinaldi, S, Jenab, M, Halkjaer, J, Jakobsen, M U, Niravong, M, Clavel-Chapelon, F, Kaaks, R, Bergmann, M, Moutsiou, E, Trichopoulou, A, Lauria, C, Sacerdote, C, Bueno-de-Mesquita, H B, Peeters, P H M, Hjartåker, A, Parr, C L, Tormo, M J, Sanchez, M J, Manjer, J, Hellström, Veronica, Mulligan, A, Spencer, E A, Riboli, E, Bingham, S, Slimani, N, Ocké, M C, Larrañaga, N, Grioni, S, van den Berg, S W, Ferrari, P, Salvini, S, Benetou, V, Linseisen, J, Wirfält, E, Rinaldi, S, Jenab, M, Halkjaer, J, Jakobsen, M U, Niravong, M, Clavel-Chapelon, F, Kaaks, R, Bergmann, M, Moutsiou, E, Trichopoulou, A, Lauria, C, Sacerdote, C, Bueno-de-Mesquita, H B, Peeters, P H M, Hjartåker, A, Parr, C L, Tormo, M J, Sanchez, M J, Manjer, J, Hellström, Veronica, Mulligan, A, Spencer, E A, Riboli, E, Bingham, S, and Slimani, N
- Abstract
These data highlight and quantify the variations and similarities in energy intake and sources of energy intake among 10 European countries. The prevalence of low-energy reporting indicates that the study of energy intake is hampered by the problem of underreporting.
- Published
- 2009
- Full Text
- View/download PDF
23. Poster Session: Right ventricular systolic function
- Author
-
Altman, M., primary, Bergerot, C., additional, Thibault, H., additional, Aussoleil, A., additional, Skuldadt Davidsen, E., additional, Barthelet, M., additional, Derumeaux, G. A., additional, Grapsa, J., additional, Zimbarra Cabrita, I., additional, Afilalo, J., additional, Paschou, S., additional, Dawson, D., additional, Durighel, G., additional, O'regan, D., additional, Howard, L., additional, Gibbs, J., additional, Nihoyannopoulos, P., additional, Morenate Navio, M., additional, Mesa Rubio, M., additional, Ortega, M. D., additional, Ruiz Ortiz, M., additional, Castillo Bernal, F., additional, Del Pino, C. L., additional, Toledano, F., additional, Alvarez-Ossorio, M. P., additional, Ojeda Pineda, S., additional, Lezo Cruz-Conde, J. S. D., additional, Jasaityte, R., additional, Claus, P., additional, Teske, A., additional, Herbots, L., additional, Verheyden, B., additional, Rademakers, F., additional, D'hooge, J., additional, Tocchetti, C. G., additional, Coppola, C., additional, Rea, D., additional, Quintavalle, C., additional, Guarino, L., additional, Castaldo, N., additional, De Lorenzo, C., additional, Condorelli, G., additional, Arra, C., additional, Maurea, N., additional, Voilliot, D., additional, Huttin, O., additional, Camara, Y., additional, Djaballah, W., additional, Carillo, S., additional, Zinzius, P., additional, Sellal, J., additional, Angioi, M., additional, Juilliere, Y., additional, Selton-Suty, C., additional, Dobrowolski, P., additional, Klisiewicz, A., additional, Florczak, E., additional, Prejbisz, A., additional, Szwench, E., additional, Rybicka, J., additional, Januszewicz, A., additional, Hoffman, P., additional, Jurado Roman, A., additional, De Dios Perez, S., additional, De Nicolas, J. M. M., additional, Diaz Anton, B., additional, Rubio Alonso, B., additional, Martin Asenjo, R., additional, Mayordomo Gomez, S., additional, Villagraz Tecedor, L., additional, Blazquez, L., additional, De Meneses, R. T., additional, Bernard, A., additional, Hernandez, A. I., additional, Reynaud, A., additional, Lerclercq, C., additional, Daubert, J., additional, Donal, E., additional, Arjan Singh, R., additional, Sivarani, S., additional, Lim, S., additional, Azman, W., additional, Almeida, M., additional, Cardim, N., additional, Fonseca, V., additional, Carmelo, V., additional, Santos, S., additional, Santos, T., additional, Toste, J., additional, Kosmala, W., additional, Orda, A., additional, Karolko, B., additional, Mysiak, A., additional, Przewlocka-Kosmala, M., additional, Farsalinos, K., additional, Tsiapras, D., additional, Kyrzopoulos, S., additional, Avramidou, E., additional, Vassilopoulou, D., additional, Voudris, V., additional, Hayrapetyan, H., additional, Adamyan, K., additional, Montero Cabezas, J., additional, Granda Nistal, C., additional, Garcia Aranda, B., additional, Sanchez Sanchez, V., additional, Sestito, A., additional, Lamendola, P., additional, Di Franco, A., additional, Lauria, C., additional, Lanza, G., additional, Kukucka, M., additional, Unbehaun, A., additional, Buz, S., additional, Mladenow, A., additional, Kuppe, H., additional, Pasic, M., additional, Habazettl, H., additional, Gemma, D., additional, Montoro Lopez, N., additional, De Celix, M. G. R., additional, Lopez Fernandez, T., additional, De Torres Alba, F., additional, Del Valle, D. I., additional, Ramirez, U., additional, Mesa, J., additional, Moreno Yanguela, M., additional, Lopez Sendon, J., additional, Eveborn, G. W., additional, Schirmer, H., additional, Lunde, P., additional, Heggelund, G., additional, Rasmussen, K., additional, Wang, Z., additional, Lasota, B., additional, Mizia-Stec, K., additional, Mizia, M., additional, Chmiel, A., additional, Adamczyk, T., additional, Chudek, J., additional, Gasior, Z., additional, Venkatesh, A., additional, Johnson, J., additional, Sahlen, A., additional, Brodin, L., additional, Winter, R., additional, Shahgaldi, K., additional, Manouras, A., additional, Valbuena, S., additional, Iniesta, A., additional, Lopez, T., additional, De Torres, F., additional, Salinas, P., additional, Garcia, S., additional, Moreno, M., additional, Lopez-Sendon, J., additional, Lebid, I., additional, Kobets, T., additional, Kuzmenko, T., additional, Katsanos, S., additional, Yiu, K., additional, Clavel, M., additional, Nina Ajmone, N., additional, Van Der Kley, F., additional, Rodes Cabau, J., additional, Schalij, M., additional, Bax, J., additional, Pibarot, P., additional, Delgado, V., additional, Fusini, L., additional, Tamborini, G., additional, Muratori, M., additional, Gripari, P., additional, Marsan, N., additional, Cefalu', C., additional, Ewe, S., additional, Maffessanti, F., additional, Pepi, M., additional, Hasselberg, N., additional, Haugaa, K., additional, Petri, H., additional, Berge, K., additional, Leren, T., additional, Bundgaard, H., additional, Edvardsen, T., additional, Ancona, R., additional, Comenale Pinto, S., additional, Caso, P., additional, Coppola, M., additional, Rapisarda, O., additional, Cavallaro, C., additional, Vecchione, F., additional, D'onofrio, A., additional, Calabro', R., additional, Rimbas, R., additional, Mihaila, S., additional, Enescu, O., additional, Patrascu, N., additional, Dragoi, R., additional, Rimbas, M., additional, Pop, C., additional, Vinereanu, D., additional, Gustafsson, S., additional, Morner, S., additional, Gronlund, C., additional, Suhr, O., additional, Lindqvist, P., additional, Di Bella, G., additional, Zito, C., additional, Minutoli, F., additional, Madaffari, A., additional, Cusma Piccione, M., additional, Mazzeo, A., additional, Massimo, R., additional, Pasquale, M., additional, Vita, G., additional, Carerj, S., additional, Rangel, I., additional, Goncalves, A., additional, Sousa, C., additional, Correia, A., additional, Martins, E., additional, Silva-Cardoso, J., additional, Macedo, F., additional, Maciel, M., additional, Pfeiffer, B., additional, Rigopoulos, A., additional, Seggewiss, H., additional, Alvarez Fuente, M., additional, Sainz Costa, T., additional, Medrano, C., additional, Navarro, M., additional, Blazquez Gamero, D., additional, Ramos, J., additional, Mellado, M., additional, De Jose, M., additional, Munoz, M., additional, Maroto, E., additional, Gargani, L., additional, Gosciniak, P., additional, Pratali, L., additional, Agoston, G., additional, Bruni, C., additional, Guiducci, S., additional, Matucci Cerinic, M., additional, Varga, A., additional, Sicari, R., additional, Picano, E., additional, Zhao, C., additional, Mei, M., additional, Yeung, C., additional, Siu, C., additional, Tse, H., additional, Florescu, M., additional, Magda, L., additional, Mincu, R., additional, Daha, I., additional, Stanescu, C. M., additional, Chirila, L., additional, Baicus, C., additional, Vlase, A., additional, Dan, G., additional, Montoro Lopez, M., additional, Florez Gomez, R., additional, Alonso Ladreda, A., additional, Itziar Soto, C., additional, Rios Blanco, J., additional, Guzman Martinez, G., additional, Lichodziejewska, B., additional, Kurnicka, K., additional, Goliszek, S., additional, Kostrubiec, M., additional, Dzikowska-Diduch, O., additional, Ciurzynski, M., additional, Labyk, A., additional, Krupa, M., additional, Palczewski, P., additional, Pruszczyk, P., additional, De Sousa, C. C., additional, Vigario, A., additional, Pinho, T., additional, Silva Cardoso, J., additional, Park, S.-J., additional, Song, J.-E., additional, Lee, Y.-J., additional, Ha, M.-R., additional, Chang, S.-A., additional, Choi, J.-O., additional, Lee, S.-C., additional, Park, S., additional, Oh, J., additional, Van De Bruaene, A., additional, De Meester, P., additional, Buys, R., additional, Vanhees, L., additional, Delcroix, M., additional, Voigt, J., additional, Budts, W., additional, Blundo, A., additional, Buccheri, S., additional, Monte, I. P., additional, Leggio, S., additional, Tamburino, C., additional, Sotaquira, M., additional, Lang, R., additional, Caiani, E., additional, Floria, M., additional, De Roy, L., additional, Xhaet, O., additional, Blommaert, D., additional, Jamart, J., additional, Gerard, M., additional, Deceuninck, O., additional, Marchandise, B., additional, Seldrum, S., additional, Schroeder, E., additional, Unsworth, B., additional, Sohaib, S., additional, Kulwant-Kaur, K., additional, Malcolme-Lawes, L., additional, Kanagaratnam, P., additional, Malik, I., additional, Ren, B., additional, Mulder, H., additional, Haak, A., additional, Van Stralen, M., additional, Szili-Torok, T., additional, Pluim, J., additional, Geleijnse, M., additional, Bosch, J., additional, Baglini, R., additional, Amaducci, A., additional, D'ancona, G., additional, Van Den Oord, S., additional, Akkus, Z., additional, Ten Kate, G., additional, Renaud, G., additional, Sijbrands, E., additional, De Jong, N., additional, Van Der Lugt, A., additional, Van Der Steen, A., additional, Schinkel, A., additional, Bjallmark, A., additional, Larsson, M., additional, Grishenkov, D., additional, Brodin, L.-A., additional, Brismar, T., additional, Paradossi, G., additional, Sveen, K. A., additional, Nerdrum, T., additional, Hanssen, K., additional, Dahl-Jorgensen, K., additional, Steine, K., additional, Cimino, S., additional, Pedrizzetti, G., additional, Tonti, G., additional, Canali, E., additional, Petronilli, V., additional, Cicogna, F., additional, Arcari, L., additional, De Luca, L., additional, Iacoboni, C., additional, Agati, L., additional, Abdel Moneim, S. S., additional, Eifert Rain, S., additional, Bernier, M., additional, Bhat, G., additional, Hagen, M., additional, Bott-Kitslaar, D., additional, Castello, R., additional, Wilansky, S., additional, Pellikka, P., additional, Mulvagh, S., additional, Delithanasis, I., additional, Celutkiene, J., additional, Kenny, C., additional, Monaghan, M., additional, Park, W., additional, Hong, G., additional, Son, J., additional, Lee, S., additional, Kim, U., additional, Park, J., additional, Shin, D., additional, Kim, Y., additional, Toutouzas, K., additional, Drakopoulou, M., additional, Aggeli, C., additional, Felekos, I., additional, Nikolaou, C., additional, Synetos, A., additional, Stathogiannis, K., additional, Tsiamis, E., additional, Siores, E., additional, Stefanadis, C., additional, Plicht, B., additional, Kahlert, P., additional, Grave, T., additional, Buck, T., additional, Konorza, T., additional, Gursoy, M., additional, Gokdeniz, T., additional, Astarcioglu, M., additional, Bayram, Z., additional, Cakal, B., additional, Karakoyun, S., additional, Kalcik, M., additional, Acar, R., additional, Kahveci, G., additional, Ozkan, M., additional, Tsang, W., additional, Weinert, L., additional, Yurdakul, S., additional, Avci, B., additional, Sahin, S., additional, Dilekci, B., additional, Aytekin, S., additional, Arenga, F., additional, Hascoet, S., additional, Martin, R., additional, Dulac, Y., additional, Peyre, M., additional, Benzouid, C., additional, Hadeed, K., additional, Acar, P., additional, Zakarkaite, D., additional, Skorniakov, V., additional, Zvironaite, V., additional, Grabauskiene, V., additional, Burca, J., additional, Ciparyte, L., additional, Laucevicius, A., additional, Di Salvo, G., additional, Rea, A., additional, D'aiello, A., additional, Del Gaizo, F., additional, Pergola, V., additional, D'andrea, A., additional, Pacileo, G., additional, Calabro, R., additional, Russo, M., additional, Dedobbeleer, C., additional, Hadefi, A., additional, Naeije, R., additional, Unger, P., additional, Mornos, C., additional, Cozma, D., additional, Ionac, A., additional, Mornos, A., additional, Valcovici, M., additional, Pescariu, S., additional, Petrescu, L., additional, Hu, K., additional, Liu, D., additional, Niemann, M., additional, Herrmann, S., additional, Cikes, M., additional, Stoerk, S., additional, Knop, S., additional, Ertl, G., additional, Bijnens, B., additional, Weidemann, F., additional, De Knegt, M., additional, Biering-Sorensen, T., additional, Sogaard, P., additional, Sivertsen, J., additional, Jensen, J., additional, Mogelvang, R., additional, Lam, W., additional, Tang, M., additional, Chan, K., additional, Yang, Y., additional, Fang, F., additional, Sun, J., additional, Yu, C., additional, Lam, Y., additional, Panoulas, V., additional, Sulemane, S., additional, Bratsas, A., additional, Konstantinou, K., additional, Francone, M., additional, Schau, T., additional, Seifert, M., additional, Ridjab, D., additional, Schoep, M., additional, Gottwald, M., additional, Neuss, M., additional, Meyhoefer, J., additional, Zaenker, M., additional, Butter, C., additional, Tarr, A., additional, Stoebe, S., additional, Pfeiffer, D., additional, Hagendorff, A., additional, Maret, E., additional, Ahlander, B.-M., additional, Bjorklund, P.-G., additional, Engvall, J., additional, Staskiewicz, G., additional, Czekajska-Chehab, E., additional, Adamczyk, P., additional, Siek, E., additional, Przybylski, P., additional, Maciejewski, R., additional, Drop, A., additional, Jimenez Rubio, C., additional, Isasti Aizpurua, G., additional, Miralles Ibarra, J., additional, Al-Mallah, M., additional, Somg, T., additional, Alam, S., additional, Chattahi, J., additional, Zweig, B., additional, Dhanalakota, K., additional, Boedeker, S., additional, Ananthasubramaniam, K., additional, Park, C., additional, March, K., additional, Jones, S., additional, Mayet, J., additional, Tillin, T., additional, Chaturvedi, N., additional, Hughes, A., additional, Hamodraka, E., additional, Kallistratos, E., additional, Karamanou, A., additional, Tsoukas, T., additional, Mavropoulos, D., additional, Kouremenos, N., additional, Zaharopoulou, I., additional, Nikolaidis, N., additional, Kremastinos, D., additional, Manolis, A., additional, Loboz-Rudnicka, M., additional, Jaroch, J., additional, Bociaga, Z., additional, Kruszynska, E., additional, Ciecierzynska, B., additional, Dziuba, M., additional, Dudek, K., additional, Uchmanowicz, I., additional, Loboz-Grudzien, K., additional, Silva, D., additional, Magalhaes, A., additional, Jorge, C., additional, Cortez-Dias, N., additional, Carrilho-Ferreira, P., additional, Silva Marques, J., additional, Portela, I., additional, Pascoa, C., additional, Nunes Diogo, A., additional, Brito, D., additional, Roosens, B., additional, Bala, G., additional, Droogmans, S., additional, Hostens, J., additional, Somja, J., additional, Delvenne, E., additional, Schiettecatte, J., additional, Lahoutte, T., additional, Van Camp, G., additional, and Cosyns, B., additional
- Published
- 2012
- Full Text
- View/download PDF
24. European prospective investigation into cancer and nutrition (EPIC) calibration study: Rationale, design and population characteristics
- Author
-
Slimani, N. Kaaks, R. Ferrari, P. Casagrande, C. Clavel-Chapelon, F. Lotze, G. Kroke, A. Trichopoulos, D. Trichopoulou, A. Lauria, C. Bellegotti, M. Ocké, M.C. Peeters, P.H.M. Engeset, D. Lund, E. Agudo, A. Larrañaga, N. Mattisson, I. Andren, C. Johansson, I. Davey, G. Welch, A.A. Overvad, K. Tjønneland, A. Van Staveren, W.A. Saracci, R. Riboli, E. and Slimani, N. Kaaks, R. Ferrari, P. Casagrande, C. Clavel-Chapelon, F. Lotze, G. Kroke, A. Trichopoulos, D. Trichopoulou, A. Lauria, C. Bellegotti, M. Ocké, M.C. Peeters, P.H.M. Engeset, D. Lund, E. Agudo, A. Larrañaga, N. Mattisson, I. Andren, C. Johansson, I. Davey, G. Welch, A.A. Overvad, K. Tjønneland, A. Van Staveren, W.A. Saracci, R. Riboli, E.
- Abstract
The European Prospective Investigation into Cancer and Nutrition (EPIC), which covers a large cohort of half a million men and women from 23 European centres in 10 Western European countries, was designed to study the relationship between diet and the risk of chronic diseases, particularly cancer. Information on usual individual dietary intake was assessed using different validated dietary assessment methods across participating countries. In order to adjust for possible systematic over- or underestimation in dietary intake measurements and correct for attenuation bias in relative risk estimates, a calibration approach was developed. This approach involved an additional dietary assessment common across study populations to re-express individual dietary intakes according to the same reference scale. A single 24-hour diet recall was therefore collected, as the EPIC reference calibration method, from a stratified random sample of 36 900 subjects from the entire EPIC cohort, using a software program (EPIC-SOFT) specifically designed to standardise the dietary measurements across study populations. This paper describes the design and populations of the calibration sub-studies set up in the EPIC centres. In addition, to assess whether the calibration sub-samples were representative of the entire group of EPIC cohorts, a series of subjects' characteristics known possibly to influence dietary intakes was compared in both population groups. This was the first time that calibration sub-studies had been set up in a large multi-centre European study. These studies showed that, despite certain inherent methodological and logistic constraints, a study design such as this one works relatively well in practice. The average response in the calibration study was 78.3% and ranged from 46.5% to 92.5%. The calibration population differed slightly from the overall cohort but the differences were small for most characteristics and centres. The overall results suggest that, after adju
- Published
- 2002
25. European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics.
- Author
-
Slimani, N, Kaaks, R, Ferrari, P, Casagrande, C, Clavel-Chapelon, F, Lotze, G, Kroke, A, Trichopoulos, D, Trichopoulou, A, Lauria, C, Bellegotti, M, Ocké, MC, Peeters, PH, Engeset, D, Lund, E, Agudo, A, Larranaga, N, Mattisson, I, Andren, C, Johansson, Ingegerd, Davey, G, Welch, AA, Overvad, K, Tjonneland, A, Van Staveren, WA, Saracci, R, Riboli, E, Slimani, N, Kaaks, R, Ferrari, P, Casagrande, C, Clavel-Chapelon, F, Lotze, G, Kroke, A, Trichopoulos, D, Trichopoulou, A, Lauria, C, Bellegotti, M, Ocké, MC, Peeters, PH, Engeset, D, Lund, E, Agudo, A, Larranaga, N, Mattisson, I, Andren, C, Johansson, Ingegerd, Davey, G, Welch, AA, Overvad, K, Tjonneland, A, Van Staveren, WA, Saracci, R, and Riboli, E
- Abstract
The European Prospective Investigation into Cancer and Nutrition (EPIC), which covers a large cohort of half a million men and women from 23 European centres in 10 Western European countries, was designed to study the relationship between diet and the risk of chronic diseases, particularly cancer. Information on usual individual dietary intake was assessed using different validated dietary assessment methods across participating countries. In order to adjust for possible systematic over- or underestimation in dietary intake measurements and correct for attenuation bias in relative risk estimates, a calibration approach was developed. This approach involved an additional dietary assessment common across study populations to re-express individual dietary intakes according to the same reference scale. A single 24-hour diet recall was therefore collected, as the EPIC reference calibration method, from a stratified random sample of 36 900 subjects from the entire EPIC cohort, using a software program (EPIC-SOFT) specifically designed to standardise the dietary measurements across study populations. This paper describes the design and populations of the calibration sub-studies set up in the EPIC centres. In addition, to assess whether the calibration sub-samples were representative of the entire group of EPIC cohorts, a series of subjects' characteristics known possibly to influence dietary intakes was compared in both population groups. This was the first time that calibration sub-studies had been set up in a large multi-centre European study. These studies showed that, despite certain inherent methodological and logistic constraints, a study design such as this one works relatively well in practice. The average response in the calibration study was 78.3% and ranged from 46.5% to 92.5%. The calibration population differed slightly from the overall cohort but the differences were small for most characteristics and centres. The overall results suggest that, after adjustmen
- Published
- 2002
- Full Text
- View/download PDF
26. European Prospective Investigation into Cancer and Nutrition (APIC) calibration study:rationale, design and population characteristics
- Author
-
JC onderzoeksprogramma Kanker, Epidemiology & Health Economics, Afdeling Dietetiek, Slimani, N., Kaaks, R., Ferrari, P., Casagrande, C., Clavel-Chapelon, F., Lotze, G., Kroke, A., Trichopoulos, D., Trichopoulou, A., Lauria, C., Bellegotti, M., Ocke, M.C., Peeters, P.H.M., Engeset, D., Lund, E., Agudo, A, Larranaga, N., Mattisson, I., Andren, C, Johansson, I., Davey, G., Welch, A.A., Overvad, K., Tjonneland, A., van Staveren, W.A., Saracci, R., Riboli, E., JC onderzoeksprogramma Kanker, Epidemiology & Health Economics, Afdeling Dietetiek, Slimani, N., Kaaks, R., Ferrari, P., Casagrande, C., Clavel-Chapelon, F., Lotze, G., Kroke, A., Trichopoulos, D., Trichopoulou, A., Lauria, C., Bellegotti, M., Ocke, M.C., Peeters, P.H.M., Engeset, D., Lund, E., Agudo, A, Larranaga, N., Mattisson, I., Andren, C, Johansson, I., Davey, G., Welch, A.A., Overvad, K., Tjonneland, A., van Staveren, W.A., Saracci, R., and Riboli, E.
- Published
- 2002
27. European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics
- Author
-
Slimani, N., Kaaks, R., Ferrari, P., Casagrande, C., Clavel-Chapelon, F., Lotze, G., Kroke, A., Trichopoulos, D., Trichopoulou, A., Lauria, C., Bellegotti, M., Ocké, M.C., Peeters, P.H.M., Engeset, D., Lund, E., Agudo, A., Larranaga, N., Mattisson, I., Andren, C., Johansson, I., Davey, G., Welch, A.A., Overvad, K., Tjonneland, A., van Staveren, W.A., Saracci, R., Riboli, E., Slimani, N., Kaaks, R., Ferrari, P., Casagrande, C., Clavel-Chapelon, F., Lotze, G., Kroke, A., Trichopoulos, D., Trichopoulou, A., Lauria, C., Bellegotti, M., Ocké, M.C., Peeters, P.H.M., Engeset, D., Lund, E., Agudo, A., Larranaga, N., Mattisson, I., Andren, C., Johansson, I., Davey, G., Welch, A.A., Overvad, K., Tjonneland, A., van Staveren, W.A., Saracci, R., and Riboli, E.
- Abstract
The European Prospective Investigation into Cancer and Nutrition (EPIC), which covers a large cohort of half a million men and women from 23 European centres in 10 Western European countries, was designed to study the relationship between diet and the risk of chronic diseases, particularly cancer. Information on usual individual dietary intake was assessed using different validated dietary assessment methods across participating countries. In order to adjust for possible systematic over- or underestimation in dietary intake measurements and correct for attenuation bias in relative risk estimates, a calibration approach was developed. This approach involved an additional dietary assessment common across study populations to re-express individual dietary intakes according to the same reference scale. A single 24-hour diet recall was therefore collected, as the EPIC reference calibration method, from a stratified random sample of 36 900 subjects from the entire EPIC cohort, using a software program (EPIC-SOFT) specifically designed to standardise the dietary measurements across study populations. This paper describes the design and populations of the calibration sub-studies set up in the EPIC centres. In addition, to assess whether the calibration sub-samples were representative of the entire group of EPIC cohorts, a series of subjects' characteristics known possibly to influence dietary intakes was compared in both population groups. This was the first time that calibration sub-studies had been set up in a large multi-centre European study. These studies showed that, despite certain inherent methodological and logistic constraints, a study design such as this one works relatively well in practice. The average response in the calibration study was 78.3% and ranged from 46.5% to 92.5%. The calibration population differed slightly from the overall cohort but the differences were small for most characteristics and centres. The overall results suggest that, after adjustmen
- Published
- 2002
28. VentMon: An open source inline ventilator tester and monitor
- Author
-
Robert L. Read, Lauria Clarke, and Geoff Mulligan
- Subjects
COVID-19 ,Open source medical device ,Ventilator ,Pandemic response ,IoT ,Respiration waveform ,Science (General) ,Q1-390 - Abstract
Humanitarian engineers responded to the pandemic ventilator shortage of March, 2020 by beginning over 100 open source ventilator projects [Robert L. Read et al. COVID-19 Vent List. Oct. 2020. url: https://docs.google.com/spreadsheets/d/1inYw5H4RiL0AC_J9vPWzJxXCdlkMLPBRdPgEVKF8DZw/edit#gid=0, Joshua M. Pearce. A review of open source ventilators for COVID-19 and future pandemics. In: F1000Research 9 (2020).]. By ventilator, we mean both an invasive ventilator (requiring intubation of the patient) and non-invasive ventilator (generally supporting spontaneously breathing). Inexpensive ventilator test equipment can facilitate projects forced to be geographically distributed by lockdowns. The VentMon is a modular, open source, IoT-enabled tester that plugs into a standard 22 mm airway between a ventilator and a physical test lung to test any ventilator. The VentMon measures flow, pressure, fractional oxygen, humidity, and temperature. Data is stored and graphed at a data lake accessible to all devlopment team members, and, eventually, clinicians. The open source design of the VentMon, its firmware, and cloud-based software may allow it to be used as a component of modular ventilators to provide a clinical readout. The software system surrounding VentMon has been designed to be as modular and composable as possible. By combining new, openly published standards for data with composable and modifiable hardware, the VentMon forms the beginning of an open system or eco-system of ventilation devices and data. Thanks to grants, 20 VentMons have been given away free of charge to pandemic response teams building open source ventilators.
- Published
- 2021
- Full Text
- View/download PDF
29. Evaluation of under- and overreporting of energy intake in the 24-hour diet recalls in the European Prospective Investigation into Cancer and Nutrition (EPIC)
- Author
-
Ferrari, P, primary, Slimani, N, additional, Ciampi, A, additional, Trichopoulou, A, additional, Naska, A, additional, Lauria, C, additional, Veglia, F, additional, Buenode-Mesquita, HB, additional, Ocke, MC, additional, Brustad, M, additional, Braaten, T, additional, José Tormo, M, additional, Amiano, P, additional, Mattisson, I, additional, Johansson, G, additional, Welch, A, additional, Davey, G, additional, Overvad, K, additional, Tjønneland, A, additional, Clavel-Chapelon, F, additional, Thiebaut, A, additional, Linseisen, J, additional, Boeing, H, additional, Hemon, B, additional, and Riboli, E, additional
- Published
- 2002
- Full Text
- View/download PDF
30. European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics
- Author
-
Slimani, N, primary, Kaaks, R, additional, Ferrari, P, additional, Casagrande, C, additional, Clavel-Chapelon, F, additional, Lotze, G, additional, Kroke, A, additional, Trichopoulos, D, additional, Trichopoulou, A, additional, Lauria, C, additional, Bellegotti, M, additional, Ocké, MC, additional, Peeters, PHM, additional, Engeset, D, additional, Lund, E, additional, Agudo, A, additional, Larrañaga, N, additional, Mattisson, I, additional, Andren, C, additional, Johansson, I, additional, Davey, G, additional, Welch, AA, additional, Overvad, K, additional, Tjønneland, A, additional, van Staveren, WA, additional, Saracci, R, additional, and Riboli, E, additional
- Published
- 2002
- Full Text
- View/download PDF
31. Human Fibroblasts as a Model for the Study of Bone Disorders
- Author
-
Lauria Claeys, Nathalie Bravenboer, Elisabeth M. W. Eekhoff, and Dimitra Micha
- Subjects
fibroblast ,preclinical model ,osteoblast ,bone disease ,osteogenic transdifferentiation ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
Bone tissue degeneration is an urgent clinical issue, making it a subject of intensive research. Chronic skeletal disease forms can be prevalent, such as the age-related osteoporosis, or rare, in the form of monogenetic bone disorders. A barrier in the understanding of the underlying pathological process is the lack of accessibility to relevant material. For this reason, cells of non-bone tissue are emerging as a suitable alternative for models of bone biology. Fibroblasts are highly suitable for this application; they populate accessible anatomical locations, such as the skin tissue. Reports suggesting their utility in preclinical models for the study of skeletal diseases are increasingly becoming available. The majority of these are based on the generation of an intermediate stem cell type, the induced pluripotent stem cells, which are subsequently directed to the osteogenic cell lineage. This intermediate stage is circumvented in transdifferentiation, the process regulating the direct conversion of fibroblasts to osteogenic cells, which is currently not well-explored. With this mini review, we aimed to give an overview of existing osteogenic transdifferentiation models and to inform about their applications in bone biology models.
- Published
- 2020
- Full Text
- View/download PDF
32. Is 2,3,5-pyrroletricarboxylic acid in hair a better risk indicator for melanoma than traditional epidemiologic measures for skin phenotype?
- Author
-
Rosso S, Zanetti R, Sánchez MJ, Nieto A, Miranda A, Mercier M, Loria D, Osterlind A, Greinert R, Chirlaque MD, Fabbrocini G, Barbera C, Sancho-Garnier H, Lauria C, Balzi D, and Zoccola M
- Abstract
This study aims to assess type of melanin as a risk indicator for skin tumors, in a sample of melanoma cases and controls within a larger multicenter study (Helios 2), held in Europe and South America in 2001-2002. In each case and control, the melanin content in hair was assessed by three methods: 1) the amount of 2,3,5-pyrroletricarboxylic acid (PTCA); 2) the absorbance ratio with ultraviolet spectroscopy; and 3) the spectra of near-infrared spectroscopy. Statistical analysis was performed in a Bayesian setting, defining priors for confounders and effect modifiers from the larger study data set. Subjects with values of PTCA of less than 85 ng/mg carried an increased risk (26 vs. seven discordant pairs: odds ratio = 4.4, 95% confidence interval: 1.52, 14.54), adjusted by hair color, eye color, and number of nevi (n = >/=40). The absorbance ratio showed a weaker and nonsignificant odds ratio of 1.5. After correction by misclassification, near-infrared spectroscopy was associated with an odds ratio of 2.3 (95% confidence interval: 1.36, 4.22). The amount of PTCA is thus a strong and independent risk indicator for melanoma. Incorporating PTCA determination into epidemiologic studies is therefore recommended. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
33. Host immunogenetics and control of human herpesvirus-8 infection.
- Author
-
Brown EE, Fallin MD, Goedert JJ, Hutchinson A, Vitale F, Lauria C, Giuliani M, Marshall V, Mbisa G, Serraino D, Messina A, Durum S, Whitby D, Chanock SJ, and Kaposi Sarcoma Genetics Working Group
- Abstract
Background. Kaposi sarcoma (KS) is primarily caused by human herpesvirus (HHV)-8 infection, and the risk is increased with high HHV-8 lytic or latent antibody titers or the detection of HHV-8 DNA in peripheral blood mononuclear cells (PBMCs). Host genes important for control of HHV-8 infection are not well characterized.Methods. In 172 HHV-8 latent nuclear antigen (LANA)-seropositive adults in Italy without KS, we examined correlations of common variants in host immune genes with the detection of HHV-8 DNA in PBMCs and with high lytic and latent antibody titers. Twenty-eight single-nucleotide polymorphisms in 14 genes were analyzed. We detected HHV-8 DNA in PBMCs with real-time amplification of the K6 gene, anti-K8.1 (lytic) titers with enzyme-linked immunosorbent assay, and anti-LANA (latent) titers with immunofluorescence.Results. Detection of HHV-8 DNA in PBMCs was not significantly related to any variant examined. In contrast, a 3-locus haplotype of IL4, which contains the -1098G allele (rs2243248), was overrepresented among subjects with high lytic titers (odds ratio [OR], 2.8 [95% confidence interval {CI}, 1.1-6.7]), compared with those with low titers, as was the functional promoter variant of IL6, C-236C (rs1800795) (OR, 3.7 [95% CI, 1.1-12.8]). Compared with subjects with low HHV-8 latent antibody titers, analysis of inferred haplotypes for IL12A revealed an overrepresentation of -798T/277A in subjects with high HHV-8 latent antibody titers (OR, 2.4 [95% CI, 1.1-5.2]).Conclusions. Our observations are the first to provide preliminary evidence suggesting that common variants in key host immune genes could influence the control of HHV-8 infection. Copyright © 2006 Infectious Diseases Society of America [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
34. Functional status of the regenerated chorda tympani nerve as assessed in a salt taste discrimination task.
- Author
-
Kopka, Stacy L. and Geran, Lauria C.
- Subjects
- *
TYMPANIC membrane , *POTASSIUM chloride , *SALT , *NERVOUS system regeneration , *RATS , *SCIENTIFIC experimentation - Abstract
Focuses on a study which tested whether the recovered ability of rats to discriminate sodium chloride from potassium chloride after chorda tympani nerve transection is linked to nerve regeneration. Methodology of the study; Results and discussion; Conclusion.
- Published
- 2000
- Full Text
- View/download PDF
35. A Molecular Epidemiology Project on Diet and Cancer: The Epic-Italy Prospective Study. Design and Baseline Characteristics of Participants
- Author
-
Palli, Domenico, Berrino, Franco, Vineis, Paolo, Tumino, Rosario, Panico, Salvatore, Masala, Giovanna, Saieva, Calogero, Salvini, Simonetta, Cerati, Marco, Pala, Valeria, Sieri, Sabina, Frasca, Graziella, Giurdanella, Maria Concetta, Sacerdote, Carlotta, Fiorini, Laura, Celentano, Egidio, Galasso, Rocco, Decarli, Adriano, Krogh, Vittorio, Palli, D, Masala, G, Saieva, C, Salvini, S, Assedi, M, Ceroti, M, Cordopatri, G, Ermini, I, Martinez, M, Tanzini, D, Zacchi, S, Zanna, I, Zappitello, C, Berrino, F, Krogh, V, Sieri, S, Pala, V, Fusconi, E, Tagliabue, G, Bellegotti, M, Evangelista, A, Del Sette, D, Foggetti, C, Vineis, P, Davico, L, Sacerdote, C, Fiorini, L, Veglia, F, Bertinetti, S, Tumino, R, Gafà, L, Frasca, G, Giurdanella, MC, Lauria, C, Martorana, C, Ruggeri, MG, Ruschena, AM, Panico, S, Celentano, E, Galasso, R, Ciardullo, AV, Del Pezzo, M, de Magistris, M Santucci, and Mattiello, A
- Abstract
EPIC-Italy is the Italian section of a larger project known as EPIC (European Prospective Investigation into Cancer and Nutrition), a prospective study on diet and cancer carried out in 10 European countries. In the period 1993-1998, EPIC-Italy completed the recruitment of 47,749 volunteers (15,171 men, 32,578 women, aged 35-65 years) in 4 different areas covered by cancer registries: Varese (12,083 volunteers) and Turin (10,604) in the Northern part of the country; Florence (13,597) and Ragusa (6,403) in Central and Southern Italy, respectively. An associate center in Naples enrolled 5,062 women. Detailed information for each individual volunteer about diet and life-style habits, anthropometric measurements and a blood sample was collected, after signing an informed consent form. A food frequency questionnaire specifically developed for the Italian dietary pattern was tested in a pilot phase. A computerized data base with the dietary and lifestyle information of each participant was completed. Blood samples were processed in the same day of collection, aliquoted (RBC, WBC, serum and plasma) and stored in liquid nitrogen containers. Follow-up procedures were validated and implemented for the identification of newly diagnosed cancer cases. Cancer incidence was related to dietary habits and biochemical markers of food consumption and individual susceptibility in order to test the role of diet-related exposure in the etiology of cancer and its interaction with other environmental or genetic determinants. The comparability of information in a prospective study design is much higher than in other studies. The availability of such a large biological bank linked to individual data on dietary and life-style exposures also provides the unique opportunity of evaluating the role of selected genotypes involved in the metabolism of chemical compounds and DNA repair, potentially related to the risk of cancer, in residents of geographic areas of Italy characterized by specific cancer risk and different dietary patterns. Baseline characteristics of participants are briefly described.
- Published
- 2003
- Full Text
- View/download PDF
36. Consumption of wild vegetables in the EPIC cohort of Ragusa (Sicily)
- Author
-
rosario tumino, Frasca, G., Giurdanella, M. C., Lauria, C., and Krogh, V.
37. A molecular epidemiology project on diet and cancer
- Author
-
Palli, D., Krogh, V., Russo, A., Berrino, F., Panico, S., Tumino, R., Vineis, P., Masala, G., calogero saieva, Cordopatri, G., Corsi, A. M., Ermini, I., Martinez, M., Rigacci, M., Sieri, S., Pala, V., Bellegotti, M., Evangelista, A., Villa, S., Davico, L., Sacerdote, C., Fiorini, L., Magnino, A., Faggiano, F., Leo, N., Gafa, L., Ruschena, A. M., Lauria, C., Celentano, E., Galasso, R., and Dello Iacovo, R.
38. Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily
- Author
-
Graubard Barry I, Airola Matt, Preiss Liliana R, Madsen Camille, Anderson Lesley A, Pelser Colleen, Perna Anna, Dazzi Carmelo, Calamusa Giuseppe, Goedert James J, Messina Angelo, Lauria Carmela, and Romano Nino
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Ecologic and in vitro studies suggest that exposures to plants or soil may influence risk of Kaposi sarcoma (KS). Methods In a population-based study of Sicily, we analyzed data on contact with 20 plants and residential exposure to 17 soils reported by 122 classic KS cases and 840 sex- and age-matched controls. With 88 KS-associated herpesvirus (KSHV) seropositive controls as the referent group, novel correlates of KS risk were sought, along with factors distinguishing seronegatives, in multinomial logistic regression models that included matching variables and known KS cofactors - smoking, cortisone use, and diabetes history. All plants were summed for cumulative exposure. Factor and cluster analyses were used to obtain scores and groups, respectively. Individual plants and soils in three levels of exposure with Ptrend ≤ 0.15 were retained in a backward elimination regression model. Results Adjusted for known cofactors, KS was not related to cumulative exposures to 20 plants [per quartile adjusted odds ratio (ORadj) 0.96, 95% confidence interval (CI) 0.73 - 1.25, Ptrend = 0.87], nor was it related to any factor scores or cluster of plants (P = 0.11 to 0.81). In the elimination regression model, KS risk was associated with five plants (Ptrend = 0.02 to 0.10) and with residential exposure to six soils (Ptrend = 0.01 to 0.13), including three soils (eutric regosol, chromic/pellic vertisol) used to cultivate durum wheat. None of the KS-associated plants and only one soil was also associated with KSHV serostatus. Diabetes was associated with KSHV seronegativity (ORadj 4.69, 95% CI 1.97 - 11.17), but the plant and soil associations had little effect on previous findings that KS risk was elevated for diabetics (ORadj 7.47, 95% CI 3.04 - 18.35) and lower for current and former smokers (ORadj 0.26 and 0.47, respectively, Ptrend = 0.05). Conclusions KS risk was associated with exposure to a few plants and soils, but these may merely be due to chance. Study of the effects of durum wheat, which was previously associated with cKS, may be warranted.
- Published
- 2010
- Full Text
- View/download PDF
39. Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30
- Author
-
Viviano Enza, Messina Angelo, Lauria Carmela, Mbulaiteye Sam M, Middeldorp Jaap, Pelser Colleen, Romano Nino, Vitale Francesco, and Goedert James J
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background To clarify the immunological alterations leading to classical Kaposi sarcoma (cKS) among people infected with KS-associated herpesvirus (KSHV). Methods In a population-based study of 119 cKS cases, 105 KSHV-seropositive controls, and 155 KSHV-seronegative controls, we quantified plasma soluble cluster of differentiation (sCD) levels and antibodies against Epstein-Barr virus nuclear antigen-1 (anti-EBNA-1) and viral capsid antigen (anti-VCA). Differences between groups in prevalence of low-tertile anti-EBNA-1 and high-tertile anti-VCA were compared by logistic regression. Continuous levels between groups and by presence of cKS co-factors among controls were compared by linear regression and Mann-Whitney-Wilcoxon methods. Results Comparisons of cKS cases to seropositive controls and of seropositive to seronegative controls revealed no significant differences. However, controls with known cKS cofactors (male sex, nonsmoking, diabetes and cortisone use) had significantly lower levels of anti-EBNA (P = 0.0001 - 0.07) and anti-VCA (P = 0.0001 - 0.03). Levels of sCD26 were significantly lower for male and non-smoking controls (Padj ≤ 0.03), and they were marginally lower with older age and cortisone use (Padj ≤ 0.09). Conclusions Anti-EBV and sCD26 levels were associated with cofactors for cKS, but they did not differ between cKS cases and matched controls. Novel approaches and broader panels of assays are needed to investigate immunological contributions to cKS.
- Published
- 2010
- Full Text
- View/download PDF
40. THE FOOT EXPERIMENT: FRAGMENTATION MEASUREMENTS IN PARTICLE THERAPY
- Author
-
E. Bellinzona, Nadia Pastrone, Alessandro Pastore, E. López Torres, M. Selvi, L. Alunni Solestizi, Pisana Placidi, E. Iarocci, F. Ferroni, Silvia Muraro, C. La Tessa, M. C. Morone, E. Spiriti, M. Ionica, P. Cerello, Y. Dong, R. Arteche Diaz, A. Zoccoli, A. Secher, Giuliana Galati, V. Lante, Elisa Fiorina, Christoph Schuy, M. De Simoni, M. Vanstalle, Luciano Ramello, K. Kanxheri, Stefano Argiro, S. M. Valle, M. Donetti, M. Garbini, A. C. Kraan, R. Ridolfi, Alberto Mengarelli, Marco Durante, N. Bartosik, A. Moggi, Valeria Rosso, M. Emde, Giacomo Traini, Angelo Schiavi, F. Raffaeli, Niccolò Camarlinghi, M. Pullia, M. Francesconi, G. De Lellis, L. Scavarda, M. Franchini, Mario Sitta, M. Villa, E. Fiandrini, M. Rovituso, Ilaria Mattei, R. Faccini, Alberto Clozza, S. Savazzi, Gabriella Sartorelli, Graziano Bruni, Matteo Morrocchi, Esther Ciarrocchi, Vincenzo Patera, A. Di Crescenzo, A. Sciubba, A. Del Guerra, G. Ambrosi, Valeri Tioukov, M. Fischetti, Veronica Ferrero, E. Scifoni, Francesco Pennazio, Livio Narici, Osamu Sato, Alessio Sarti, Adele Lauria, Francesco Tommasino, S. Colombi, Giancarlo Sportelli, M. G. Bisogni, A. Stahl, V. Gentile, S. Bianucci, R. Mirabelli, Leonello Servoli, U. Weber, Luca Galli, R. Spighi, Nicola Belcari, M. Marafini, A. Embriaco, C. Sanelli, S. Tommasini, C. Finck, Maria Cristina Montesi, P. Carra, G. Silvestre, A. Alexandrov, R. Hetzel, Silvia Biondi, Giuseppe Battistoni, Giuseppe Giraudo, A. Alexandrov, L. Alunni Solestizi, G. Ambrosi, S. Argirò, R. Arteche Diaz, N. Bartosik, G. Battistoni, N. Belcari, E. Bellinzona, S. Bianucci, S. Biondi, M. G. Bisogni, G. Bruni, N. Camarlinghi, P. Carra, P. Cerello, E. Ciarrocchi, A. Clozza, S. Colombi, G. De Lellis, A. Del Guerra, M. De Simoni, A. Di Crescenzo, M. Donetti, Y. Dong, M. Durante, A. Embriaco, M. Emde, R. Faccini, V. Ferrero, F. Ferroni, E. Fiandrini, C. Finck, E. Fiorina, M. Fischetti, M. Francesconi, M. Franchini, G. Galati, L. Galli, M. Garbini, V. Gentile, G. Giraudo, R. Hetzel, E. Iarocci, M. Ionica, K. Kanxheri, A. C. Kraan, V. Lante, A. Lauria, C. La Tessa, E. Lopez Torres, M. Marafini, I. Mattei, A. Mengarelli, R. Mirabelli, A. Moggi, M. C. Montesi, M. C. Morone, M. Morrocchi, S. Muraro, L. Narici, A. Pastore, N. Pastrone, V. Patera, F. Pennazio, P. Placidi, M. Pullia, F. Raffaeli, L. Ramello, R. Ridolfi, V. Rosso, M. Rovituso, C. Sanelli, A. Sarti, G. Sartorelli, O. Sato, S. Savazzi, L. Scavarda, A. Schiavi, C. Schuy, E. Scifoni, A. Sciubba, A. Sécher, M. Selvi, L. Servoli, G. Silvestre, M. Sitta, R. Spighi, E. Spiriti, G. Sportelli, A. Stahl, V. Tioukov, S. Tommasini, F. Tommasino, G. Traini, S. M. Valle, M. Vanstalle, M. Villa, U. Webe, A. Zoccoli, Alexandrov, A., Alunni Solestizi, L., Ambrosi, G., Argirò, S., Arteche Diaz, R., Bartosik, N., Battistoni, G., Belcari, N., Bellinzona, E., Bianucci, S., Biondi, S., Bisogni, M. G., Bruni, G., Camarlinghi, N., Carra, P., Cerello, P., Ciarrocchi, E., Clozza, A., Colombi, S., De Lellis, G., Del Guerra, A., De Simoni, M., Di Crescenzo, A., Donetti, M., Dong, Y., Durante, M., Embriaco, A., Emde, M., Faccini, R., Ferrero, V., Ferroni, F., Fiandrini, E., Finck, C., Fiorina, E., Fischetti, M., Francesconi, M., Franchini, M., Galati, G., Galli, L., Garbini, M., Gentile, V., Giraudo, G., Hetzel, R., Iarocci, E., Ionica, M., Kanxheri, K., Kraan, A. C., Lante, V., Lauria, A., La Tessa, C., Lopez Torres, E., Marafini, M., Mattei, I., Mengarelli, A., Mirabelli, R., Moggi, A., Montesi, M. C., Morone, M. C., Morrocchi, M., Muraro, S., Narici, L., Pastore, A., Pastrone, N., Patera, V., Pennazio, F., Placidi, P., Pullia, M., Raffaeli, F., Ramello, L., Ridolfi, R., Rosso, V., Rovituso, M., Sanelli, C., Sarti, A., Sartorelli, G., Sato, O., Savazzi, S., Scavarda, L., Schiavi, A., Schuy, C., Scifoni, E., Sciubba, A., Sécher, A., Selvi, M., Servoli, L., Silvestre, G., Sitta, M., Spighi, R., Spiriti, E., Sportelli, G., Stahl, A., Tioukov, V., Tommasini, S., Tommasino, F., Traini, G., Valle, S. M., Vanstalle, M., Villa, M., Weber, U., and Zoccoli, A.
- Subjects
Nuclear physics ,Particle therapy ,Materials science ,Physics::Instrumentation and Detectors ,medicine.medical_treatment ,Quantitative Biology::Tissues and Organs ,Physics::Medical Physics ,Media Technology ,medicine ,Fragmentation (computing) ,Nuclear Experiment ,fragmentation, hadrotherapy, cross section ,Settore FIS/07 - Fisica Applicata(Beni Culturali, Ambientali, Biol.e Medicin) - Abstract
Charged Particle Therapy (CPT) is a powerful radiotherapy technique for the treatment of deep-seated tumours characterized by a large dose released in the Bragg peak area (corresponding to the tumour region) and a small dose delivered to the surrounding healthy tissues. The precise measurement of the fragments produced in the nuclear interactions of charged particle beams with patient tissues is a crucial task to improve the clinical treatment plans. The FOOT (FragmentatiOn Of Target) experiment is an international project, funded by the Istituto Nazionale di Fisica Nucleare (INFN), aimed to study the dose released by the tissues and particle beams fragmentation. The target (16O, 12C) fragmentation induced by 150-400 MeV/n proton beams will be studied via the inverse kinematic approach, where 16O and 12C therapeutic beams collide on graphite and hydrocarbon target to provide the cross section on Hydrogen. A table-top detector is being developed and it includes a drift chamber as a beam monitor upstream of the target to measure the beam direction, a magnetic spectrometer based on silicon pixel and strip detectors, a scintillating crystal calorimeter able to stop the heavier produced fragments, and a ΔE detector, with TOF capability, for the particle identification. A setup based on the concept of the “Emulsion Cloud Chamber”, coupled with the interaction region of the electronic FOOT setup, will complement the physics program by measuring lighter charged fragments to extend the angular acceptance up to about 70 degrees. In this work, the experimental design and the requirements of the FOOT experiment will be discussed and preliminary results on the emulsion spectrometer tests will be presented.
- Published
- 2019
41. Risk of Classic Kaposi Sarcoma With Combinations of Killer Immunoglobulin-Like Receptor and Human Leukocyte Antigen Loci: A Population-Based Case-control Study
- Author
-
Xiaojiang Gao, Maureen P. Martin, Ying Qi, Denise Whitby, Carmela Lauria, Mary Carrington, James J. Goedert, Francesco Vitale, Goedert, J., Martin, M., Vitale, F., Lauria, C., Whitby, D., Qi, Y., Gao, X., and Carrington, M.
- Subjects
0301 basic medicine ,Genotype ,viruses ,case-control study ,Population ,chemical and pharmacologic phenomena ,Human leukocyte antigen ,Biology ,Lymphocyte Activation ,Settore MED/42 - Igiene Generale E Applicata ,Major Articles and Brief Reports ,03 medical and health sciences ,Receptors, KIR ,natural killer–cell immunoglobulin-like receptors ,HLA Antigens ,Risk Factors ,Seroepidemiologic Studies ,human leukocyte antigen ,otorhinolaryngologic diseases ,HLA-B Antigens ,Humans ,Immunology and Allergy ,Seroprevalence ,Genetic Predisposition to Disease ,human genetic ,education ,Sarcoma, Kaposi ,education.field_of_study ,Classic Kaposi Sarcoma ,Case-control study ,virus diseases ,Kaposi sarcoma ,Odds ratio ,major histocompatibility complex ,030104 developmental biology ,Infectious Diseases ,Gene Expression Regulation ,Italy ,Case-Control Studies ,human genetics ,human leukocyte antigens ,Herpesvirus 8, Human ,Immunology - Abstract
BACKGROUND Kaposi sarcoma (KS) is a complication of KS-associated herpesvirus (KSHV) infection. Other oncogenic viral infections and malignancies are associated with certain HLA alleles and their natural killer (NK) cell immunoglobulin-like receptor (KIR) ligands. We tested whether HLA-KIR influences the risk of KSHV infection or KS. METHODS In population-based case-control studies, we compared HLA class I and KIR gene frequencies in 250 classic (non-AIDS) KS cases, 280 KSHV-seropositive controls, and 576 KSHV-seronegative controls composing discovery and validation cohorts. Logistic regression was used to calculate sex- and age-adjusted odds ratios (ORs) and 95% confidence intervals. RESULTS In both the discovery and validation cohorts, KS was associated with HLA-A*11:01 (adjusted OR for the combined cohorts, 0.4; P = .002) and HLA-C*07:01 (adjusted OR, 1.6; P = .002). Consistent associations across cohorts were also observed with activating KIR3DS1 plus HLA-B Bw4-80I and homozygosity for HLA-C group 1. With KIR3DS1 plus HLA-B Bw4-80I, the KSHV seroprevalence was 40% lower (adjusted OR for the combined cohorts, 0.6; P = .01), but the KS risk was 2-fold higher (adjusted OR, 2.1; P = .002). Similarly, the KSHV seroprevalence was 40% lower (adjusted OR, 0.6; P = .01) but the KS risk 80% higher with HLA-C group 1 homozygosity (adjusted OR, 1.8; P = .005). CONCLUSIONS KIR-mediated NK cell activation may decrease then risk of KSHV infection but enhance KSHV dissemination and progression to KS if infection occurs.
- Published
- 2015
- Full Text
- View/download PDF
42. Sensori e mems: applicazioni per il rilievo del costruito / Sensors and mems: applications for surveying the built environment
- Author
-
CATUOGNO, RAFFAELE, M. Lauria, C. Trombetta, and Catuogno, Raffaele
- Subjects
mems, laser scanner, survey, environment - Abstract
Le attività di ricerca svolte presso il Centro Interdipartimentale di Ricerca UrbanEco si propongono di esplorare le possibilità del rilievo e della rappresentazione, di integrare laser-scanning e fotogrammetria, nonché sviluppare nuovi apparati definibili low-cost basati sulla sensoristica mems. UrbanEco ha sempre avuto come mission l’innovazione sia hardware che software dei sistemi utilizzati nei lavori realizzati, sia in ambito didattico che di ricerca. L’utilizzo di diverse tipologie di laser scanner, in particolare il Faro Focus3D, da una parte ha consentito operazioni speditive nell’acquisizioni dei dati, dall’altra ha permesso modifiche ad un hardware versatile capace di interfacciarsi con un microcontrollore come Arduino, che ha apportato migliorie che ne hanno aumentato e diversificato lo spettro di azione. Research activities carried out at the UrbanEco Interdepartmental Research Centre aim to explore surveying and representation options, integrating laser-scanning and photogrammetry as well as developing new systems definable as low-cost and based on MEMS. The UrbanEco has always considered its mission to be innovation, of both hardware and software, in the systems used in its activities involving both teaching and research. Thanks to the use of different types of laser scanners, in particular the Faro Focus3D, it has been possible, on the one hand to perform rapid data acquisition, and on the other to modify versatile hardware capable of interfacing with a micro-controller like Arduino where improvements have extended and diversified its range of action.
- Published
- 2016
43. A Multiplex Panel of Plasma Markers of Immunity and Inflammation in Classical Kaposi Sarcoma
- Author
-
Mark N. Polizzotto, Carmela Lauria, James J. Goedert, Meredith S. Shiels, Charles S. Rabkin, Ligia A. Pinto, Francesco Vitale, Troy J. Kemp, Peter Aka, Aka, PV, Kemp, TJ, Rabkin, CS, Shiels, MS, Polizzotto, MN, Lauria, C, Vitale, F, Pinto, LA, and Goedert, JJ
- Subjects
Male ,medicine.medical_treatment ,Inflammation ,Biology ,Settore MED/42 - Igiene Generale E Applicata ,Pathogenesis ,Kaposi Sarcoma ,Plasma Markers of Inflammation ,Major Articles and Brief Reports ,Immunity ,medicine ,Humans ,Immunology and Allergy ,Prospective cohort study ,Sarcoma, Kaposi ,Case-control study ,virus diseases ,Plasma Markers of Immunity ,medicine.disease ,Squamous intraepithelial lesion ,Infectious Diseases ,Cytokine ,Italy ,Case-Control Studies ,Immunology ,Sarcoma ,medicine.symptom ,Biomarkers - Abstract
Kaposi sarcoma (KS) risk is affected by perturbed immunity. Herein, we compared plasma from 15 human immunodeficiency virus (HIV)–negative classic KS cases to plasma from 29 matched controls, using a multiplex panel of immunity markers. Of 70 markers, CXCL10 (IP-10), sIL-1RII, sIL-2RA, and CCL3 (MIP-1A) were strongly and significantly associated with KS, after adjustment for age and smoking status. These and previous observations are consistent with a tumor-promoting role for these cytokines, particularly CXCL10, but the small sample size and case-control design preclude firm conclusions on KS risk or pathogenesis. Larger, well-designed prospective studies are needed to better assess the association of these markers with KS.
- Published
- 2015
44. Socio-economic and other correlates of Kaposi sarcoma-associated herpesvirus seroprevalence among older adults in Sicily
- Author
-
Lesley A. Anderson, Lorenzo Gafà, Denise Whitby, Nino Romano, Carmela Lauria, Francesco Vitale, Elizabeth E. Brown, Barry I. Graubard, Colleen Pelser, Angelo Messina, James J. Goedert, Pelser, C, Vitale, F, Whitby, D, Graubard, BI, Messina, A, Gafà, L, Brown, EE, Anderson, LA, Romano, N, Lauria, C, and Goedert, JJ
- Subjects
Adult ,Male ,medicine.medical_specialty ,Population ,Logistic regression ,Antibodies, Viral ,Settore MED/42 - Igiene Generale E Applicata ,Article ,Serology ,Risk Factors ,Seroepidemiologic Studies ,Virology ,Epidemiology ,medicine ,Seroprevalence ,Gammaherpesvirinae ,Humans ,education ,Sicily ,Aged ,Aged, 80 and over ,education.field_of_study ,biology ,business.industry ,Odds ratio ,Herpesviridae Infections ,Middle Aged ,biology.organism_classification ,KSHV seroprevalence, socio-economic correlates, elderly, Sicily ,Confidence interval ,Infectious Diseases ,Socioeconomic Factors ,Herpesvirus 8, Human ,Female ,business - Abstract
The virus that causes Kaposi sarcoma, KS-associated herpesvirus (KSHV, also known as human herpesvirus 8) has an unusual distribution and poorly characterized modes of transmission. To clarify these issues, socio-demographic correlates of KSHV seroprevalence were examined in a population-based study. In 1,154 randomly sampled adults (aged 32- 92, mean 71 years) throughout Sicily, KSHV antibodies were detected with four assays and a conservative algorithm. Seroprevalence was re-weighted to the population. Odds ratios with 95% confidence intervals (OR, CI) from multivariate logistic regression were used to estimate associations of seroprevalence with interview data. KSHV seroprevalence was 8.5%, including 5.3% among men (N = 848) and 11.5% among women (N = 306, P = 0.22). Seroprevalence was higher with residence in a smaller community during childhood (P(trend) = 0.03) and working with plants/soil during adulthood (OR 2.9, CI 1.1-7.9); these were especially strong among women. Among men, seroprevalence was significantly associated with lower education (OR 2.6, CI 1.1-5.9) and migration to a larger community (OR 0.3, CI 0.1-0.9). Other demographic and household variables were unrelated to seroprevalence. From these data, KSHV in Sicily appears to be related to low socio-economic status, but micro-endemicity in small communities cannot be excluded.
- Published
- 2009
45. Risk Factors for Classical Kaposi Sarcoma in a Population-based Case-control Study in Sicily
- Author
-
Carmela Lauria, James J. Goedert, Elizabeth E. Brown, Francesco Vitale, Lesley A. Anderson, Denise Whitby, Nino Romano, Barry I. Graubard, Lorenzo Gafà, Yan Li, Angelo Messina, ANDERSON LA, LAURIA C, ROMANO N, BROWN EE, WHITBY D, GRAUBARD BI, LI Y, MESSINA A, GAFA L, VITALE F, and AND GOEDERT JJ
- Subjects
Adult ,Male ,medicine.medical_specialty ,Epidemiology ,Population ,Settore MED/42 - Igiene Generale E Applicata ,Article ,Risk Factors ,Internal medicine ,medicine ,CKS, risk factors, Sicily ,Humans ,education ,Sarcoma, Kaposi ,Sicily ,Aged ,Aged, 80 and over ,education.field_of_study ,Chi-Square Distribution ,Classic Kaposi Sarcoma ,business.industry ,Incidence ,Incidence (epidemiology) ,Smoking ,Case-control study ,virus diseases ,Cancer ,Odds ratio ,Middle Aged ,medicine.disease ,Logistic Models ,Oncology ,Case-Control Studies ,Immunology ,Female ,Sarcoma ,business ,Chi-squared distribution - Abstract
Background: Classical Kaposi sarcoma is a rare complication of Kaposi sarcoma-associated herpes virus (KSHV) infection. We conducted a population-based, frequency-matched case-control study in Sicily to further investigate the reported inverse relationship between smoking and classical Kaposi sarcoma and to identify other factors associated with altered risk. Methods: All incident, histologically confirmed classical Kaposi sarcoma cases in Sicily were eligible. A two-stage cluster sample design was applied to select population controls. KSHV seropositivity was determined using four antibody assays (K8.1 and orf73 enzyme immunoassays and two immunofluorenscence assays). Using SAS-callable SUDAAN, we compared the characteristics of classical Kaposi sarcoma cases and KSHV-seropositive controls. Odds ratios (OR) and 95% confidence intervals (CI) are presented. Results: In total, 142 classical Kaposi sarcoma cases and 123 KSHV-seropositive controls were recruited. Current cigarette smoking was associated with reduced risk of classical Kaposi sarcoma amongst males (OR, 0.20; 95% CI, 0.06-0.67). Edema was associated with classical Kaposi sarcoma, but only when it presented on the lower extremities (OR, 3.65; 95% CI, 1.62-8.23). Irrespective of presentation site, diabetes and oral corticosteroid medications were associated with increased risk (OR, 4.73; 95% CI, 2.02-11.1 and OR, 2.34; 95% CI, 1.23-4.45, respectively). Never smoking, diabetes, and oral corticosteroid medication use were all independently associated with classical Kaposi sarcoma risk. Discussion: We confirmed previous reports that cigarette smoking was associated with a reduced risk of classical Kaposi sarcoma, and we found that risk was lowest among current smokers. We also found that classical Kaposi sarcoma risk was strongly and independently associated with oral corticosteroid use and diabetes. Corroboration of these observations and investigation of possible underlying mechanisms are warranted. (Cancer Epidemiol Biomarkers Prev 2008;17(12):3435–43)
- Published
- 2008
- Full Text
- View/download PDF
46. Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma
- Author
-
Denise Whitby, Paola Cordiali-Fei, Elizabeth E. Brown, Diego Serraino, James J. Goedert, Angelo Messina, Anthony J. Alberg, Georgina Mbisa, Francesco Vitale, Christine J. Gamache, Carmela Lauria, Vickie Marshall, BROWN EE, WHITBY D, VITALE F, MARSHALL V, MBISA G, GAMACHE C, LAURIA C, ALBERG AJ, SERRAINO D, CORDIALI-FEI P, MESSINA A, and GOEDERT JJ
- Subjects
Adult ,Male ,Cancer Research ,HIV Infections ,Hematocrit ,medicine.disease_cause ,Peripheral blood mononuclear cell ,Herpesviridae ,chemistry.chemical_compound ,Antigen ,Risk Factors ,medicine ,Gammaherpesvirinae ,Humans ,Sarcoma, Kaposi ,Aged ,Aged, 80 and over ,medicine.diagnostic_test ,biology ,business.industry ,Antibody titer ,Neopterin ,Middle Aged ,biology.organism_classification ,Kaposi Sarcoma, human herpesvirus-8, immunity ,Oncology ,chemistry ,Italy ,Immunology ,Multivariate Analysis ,Disease Progression ,HIV-1 ,Female ,business ,Viral load ,Biomarkers - Abstract
BACKGROUND Classic Kaposi sarcoma (CKS) is an inflammatory-mediated neoplasm that develops in the presence of KS-associated herpesvirus (KSHV) and immune perturbation. In the current study, the authors compared CKS cases with age-matched and sex-matched KSHV-seropositive controls without human immunodeficiency virus-1 infection and markers of viral control, blood counts, CD4-positive and CD8-positive lymphocytes, and serum β-2-microglobulin and neopterin levels. METHODS Viral loads were detected using real-time amplification of the KSHV-K6 and EBV-pol genes, anti-K8.1 (lytic) titers were detected by enzyme-linked immunoadsorbent assay, and antilatent nuclear antigen (LANA) titers were detected using immunofluorescence. Odds ratios (OR) and 95% confidence intervals (95% CI) were calculated using logistic regression adjusted for sex, age, and study site. RESULTS Peripheral blood mononuclear cells (PBMC) KSHV DNA detection (P ≤ .0001) and high KSHV lytic (>1:1745; P ≤ .0001) and latent (>1:102,400; P = .03) antibody titers were found to be positively associated with CKS risk. Antibody titers were higher in cases with lesions compared with cases without lesions (P ≤.05). The detection of Epstein-Barr virus (EBV) DNA in PBMCs was not found to be associated with CKS (P = .95). Independent of PBMC KSHV DNA, CKS risk was found to be positively associated with reduced hematocrit (
- Published
- 2006
47. Host immunogenetics and control of human herpesvirus-8 infection
- Author
-
James J. Goedert, M. Daniele Fallin, Francesco Vitale, Scott K. Durum, Vickie Marshall, Diego Serraino, Massimo Giuliani, Georgina Mbisa, Amy Hutchinson, Denise Whitby, Angelo Messina, Elizabeth E. Brown, Stephen J. Chanock, Carmela Lauria, BROWN EE, FALLIN D, GOEDERT JJ, HUTCHINSON A, VITALE, F, LAURIA C, GIULIANI M, MARSHALL V, MBISA G, SERRAINO D, MESSINA A, DURUM S, WHITBY D, CHANOCK SJ, and TRAMUTO, F
- Subjects
Adult ,Male ,Vascular Endothelial Growth Factor A ,Simplexvirus ,food.ingredient ,viruses ,Immunogenetics ,Biology ,medicine.disease_cause ,Antibodies, Viral ,Herpesviridae ,food ,Antigen ,Latent Nuclear Antigen ,Risk Factors ,medicine ,Immunology and Allergy ,Humans ,Aged ,Antibody titer ,virus diseases ,Herpesviridae Infections ,biochemical phenomena, metabolism, and nutrition ,Middle Aged ,Virology ,Editorial Commentary ,Titer ,Infectious Diseases ,Lytic cycle ,Haplotypes ,Immunology ,DNA, Viral ,Herpesvirus 8, Human ,Leukocytes, Mononuclear ,Cytokines ,Female - Abstract
BACKGROUND: Kaposi sarcoma (KS) is primarily caused by human herpesvirus (HHV)-8 infection, and the risk is increased with high HHV-8 lytic or latent antibody titers or the detection of HHV-8 DNA in peripheral blood mononuclear cells (PBMCs). Host genes important for control of HHV-8 infection are not well characterized. METHODS: In 172 HHV-8 latent nuclear antigen (LANA)-seropositive adults in Italy without KS, we examined correlations of common variants in host immune genes with the detection of HHV-8 DNA in PBMCs and with high lytic and latent antibody titers. Twenty-eight single-nucleotide polymorphisms in 14 genes were analyzed. We detected HHV-8 DNA in PBMCs with real-time amplification of the K6 gene, anti-K8.1 (lytic) titers with enzyme-linked immunosorbent assay, and anti-LANA (latent) titers with immunofluorescence. RESULTS: Detection of HHV-8 DNA in PBMCs was not significantly related to any variant examined. In contrast, a 3-locus haplotype of IL4, which contains the -1098G allele (rs2243248), was overrepresented among subjects with high lytic titers (odds ratio [OR], 2.8 [95% confidence interval {CI}, 1.1-6.7]), compared with those with low titers, as was the functional promoter variant of IL6, C-236C (rs1800795) (OR, 3.7 [95% CI, 1.1-12.8]). Compared with subjects with low HHV-8 latent antibody titers, analysis of inferred haplotypes for IL12A revealed an overrepresentation of -798T/277A in subjects with high HHV-8 latent antibody titers (OR, 2.4 [95% CI, 1.1-5.2]). CONCLUSIONS: Our observations are the first to provide preliminary evidence suggesting that common variants in key host immune genes could influence the control of HHV-8 infection.
- Published
- 2006
48. Trajectories and tipping points of piñon-juniper woodlands after fire and thinning.
- Author
-
Phillips ML, Lauria C, Spector T, Bradford JB, Gehring C, Osborne BB, Howell A, Grote EE, Rondeau RJ, Trimber GM, Robinson B, and Reed SC
- Subjects
- Ecosystem, Forests, Soil, Juniperus, Pinus, Fires
- Abstract
Piñon-juniper (PJ) woodlands are a dominant community type across the Intermountain West, comprising over a million acres and experiencing critical effects from increasing wildfire. Large PJ mortality and regeneration failure after catastrophic wildfire have elevated concerns about the long-term viability of PJ woodlands. Thinning is increasingly used to safeguard forests from fire and in an attempt to increase climate resilience. We have only a limited understanding of how fire and thinning will affect the structure and function of PJ ecosystems. Here, we examined vegetation structure, microclimate conditions, and PJ regeneration dynamics following ~20 years post-fire and thinning treatments. We found that burned areas had undergone a state shift that did not show signs of returning to their previous state. This shift was characterized by (1) distinct plant community composition dominated by grasses; (2) a lack of PJ recruitment; (3) a decrease in the sizes of interspaces in between plants; (4) lower abundance of late successional biological soil crusts; (5) lower mean and minimum daily soil moisture values; (6) lower minimum daily vapor pressure deficit; and (7) higher photosynthetically active radiation. Thinning created distinct plant communities and served as an intermediate between intact and burned communities. More intensive thinning decreased PJ recruitment and late successional biocrust cover. Our results indicate that fire has the potential to create drier and more stressful microsite conditions, and that, in the absence of active management following fire, there may be shifts to persistent ecological states dominated by grasses. Additionally, more intensive thinning had a larger impact on community structure and recruitment than less intensive thinning, suggesting that careful consideration of goals could help avoid unintended consequences. While our results indicate the vulnerability of PJ ecosystems to fire, they also highlight management actions that could be adapted to create conditions that promote PJ re-establishment., (© 2024 John Wiley & Sons Ltd. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.)
- Published
- 2024
- Full Text
- View/download PDF
49. Real-World Effectiveness of Calcitonin Gene-Related Peptide-Binding Monoclonal Antibodies for Migraine Prevention: A Systematic Review.
- Author
-
Zovi A, Langella R, Aloisi AC, De Giorgio C, Del Vecchio M, Dondi C, Handschin G, Lauria C, Marchetti C, Martinazzoli O, Nozza R, Scalzi V, Tratta E, Jemos C, and Lasala R
- Abstract
Background: Migraine is a neurological disease with a high incidence. The new anti-calcitonin gene-related peptide monoclonal antibodies (anti-CGRP mAbs) have demonstrated effectiveness in preventing episodic and chronic migraine., Objective: To collect evidence of the real-world effectiveness of anti-CGRP mAbs by assessing outcomes such as reduction in monthly migraine days (MMDs), reduction in monthly headache days (MHDs), and percentage of patients having a 50% reduction in MMDs., Data Sources: The PubMed database was searched for the period from inception to October 20, 2021., Study Selection and Data Extraction: Of interest for this review were studies that evaluated the real-world effectiveness of anti-CGRP mAbs in terms of MMDs and reduction in MHDs. The search terms included "migraine", "monthly migraine days", and various drug names. The data are reported in terms of patients' baseline characteristics and treatment effectiveness., Data Synthesis: A total of 46 studies were evaluated, of which 30 (enrolling a total of 4273 patients across 10 countries) were included in the systematic review. The greatest absolute reduction in MMD was from 20.4 at baseline to 10.7 after 3 months of treatment. After 6 months, the greatest absolute difference was 10, relative to baseline. The largest absolute reduction in MHD at 3 months was from 22 to 8, whereas at 6 months, the greatest absolute reduction in MHD was 13. The treatment could be considered clinically effective (≥ 50% reduction in MMDs) for 41% of patients at 3 months and about 44% of patients at 6 months., Conclusions: Despite substantial variability in baseline values, this review confirmed the effectiveness of anti-CGRP mAbs, which yielded important clinical reductions in both MMDs and MHDs., Competing Interests: Competing interests: Andrea Zovi received a grant from Chiesi to attend a national congress. No other competing interests were declared. z, (2024 Canadian Society of Hospital Pharmacists. All content in the Canadian Journal of Hospital Pharmacy is copyrighted by the Canadian Society of Hospital Pharmacy. In submitting their manuscripts, the authors transfer, assign, and otherwise convey all copyright ownership to CSHP.)
- Published
- 2024
- Full Text
- View/download PDF
50. Echocardiographic markers of early alcoholic cardiomyopathy: Six-month longitudinal study in heavy drinking patients.
- Author
-
Mirijello A, Sestito L, Lauria C, Tarli C, Vassallo GA, Antonelli M, d'Angelo C, Ferrulli A, Crea F, Cossari A, Leggio L, De Cosmo S, Gasbarrini A, and Addolorato G
- Subjects
- Biomarkers, Echocardiography, Female, Humans, Longitudinal Studies, Male, Ventricular Function, Left, Cardiomyopathy, Alcoholic diagnostic imaging, Ventricular Dysfunction, Left epidemiology
- Abstract
Background: The development of alcoholic cardiomyopathy (ACM) is related to chronic excessive alcohol use. However, features of early-stage ACM are still unclear. We assessed echocardiographic characteristics of patients with alcohol dependence (DSM-IV criteria) during a six-month treatment period., Methods: Active drinking patients, heavy alcohol users, without heart disease, referred to our Alcohol Addiction Unit were enrolled in the study. After signing informed consent, patients started outpatient treatment program. Echocardiography was performed at enrollment, then three and six months afterwards, by cardiologists blinded to drinking status., Results: Forty-three patients (36 males, 7 females) were enrolled. At six months, 20 patients (46.5%) reduced alcohol consumption below heavy drinking levels. Although within normal range, baseline mean IVS thickness and mean LVDD were significantly higher (p < 0.001) and mean EF significantly reduced (p = 0.009), as compared to age-matched mean references. Mean E/A ratio, DcT and LA diameter were significantly different (p < 0.001) from mean references, but within normal range. Baseline mean E/e' ratio was significantly higher than the mean reference (p < 0.001) and out of the normal range. A significant correlation between the number of drinks per drinking days in the 7 days before baseline assessment and E/e' ratio was observed (p = 0.028). After six months, a trend-level reduction of mean E/e' ratio (p = 0.051) was found in the whole sample; this reduction was statistically significant (p = 0.041) among patients reducing drinking, compared to baseline., Conclusions: Altered E/e' ratio may characterize early-ACM before the occurrence of relevant echocardiographic alterations. The reduction of alcohol consumption could restore this alteration after six months., (Copyright © 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.